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Background: Ruptured abdominal aortic aneurysm (RAAA) is a life-threatening event, and 
without operative treatment the patient will die. The overall mortality can be as high as 80–90%; 
thus repair of RAAA should be attempted whenever feasible. The situation should be assessed  
in the face of a high rate of operative mortality and postoperative quality of life. The operative 
mortality rate has remained unchanged over the past few decades. In addition to mortality, the 
quality of life (QoL) has become an increasingly important outcome measure in vascular 
surgery.      
 
Aim of the study: To evaluate outcomes of RAAA and to find out predictors of mortality.  
 
Patients and Methods: In Helsinki and Uusimaa district 626 patients were identified to have 
RAAA in 1996–2004. Altogether 352 of them were admitted to Helsinki University Central 
Hospital (HUCH). Based on data from the nationwide Finnvasc Registry, 836 RAAA patients 
underwent repair of RAAA in 1991–1999. First, the 30-day operative mortality was assessed in 
both groups, and hospital and population-based mortality also in Helsinki and Uusimaa district. 
Regional centralisation and improving in-hospital quality included centralisation of emergency 
vascular surgery, strengthening of emergency preparedness, and better availability of 
postoperative care in the intensive care unit. The effect of these changes on the outcome of 
RAAA was assessed. Secondly, QoL was evaluated by a validated, self-administrated QoL 
questionnaire (RAND-36) of survivors of RAAA in 1996–2000. The study was retrospective 
with cross-sectional QoL assessment. Thirdly, quality-adjusted life years (QALYs), which 
measure length and QoL, were calculated for each RAAA patient, using the EQ-5D index  
(EQ-5D QoL questionnaire) and estimation of life expectancy according to age- and sex-adjusted 
population (1996–2002). Fourth, the predictors of outcome after RAAA were assessed at 
admission and 48 hours after repair of RAAA (1999-2003).  
 
Main results: The 30-day operative mortality rate was 38% in HUCH and 44% nationwide, 
whereas the hospital mortality was 45% in HUCH. Hospital mortality for RAAA patients over 
80 years of age was 66%. Population-based mortality was 69% in 1996–2004 and 56% in 2003–
2004. After organisational changes were undertaken, the mortality decreased significantly at all 
levels, even at the population level. Among the survivors, the QoL after RAAA was almost equal 
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when compared with norms of age- and sex-matched controls; only physical functioning (one out 
of eight domains) was slightly impaired (RAND-36). Successful repair of RAAA gave a mean of 
4.1 (0–30.9) QALYs for all RAAA patients, although also non-survivors were included. The 
preoperative Glasgow Aneurysm Score was an independent predictor of 30-day operative 
mortality after RAAA with reasonable discriminatory ability (AUC 0.75 (95% CI 0.72–0.78)). It 
also predicted the outcome at 48- hours for initial survivors of repair of RAAA (AUC 0.67 (95% 
CI 0.56–0.78)). A high Glasgow Aneurysm Score and high age were associated with low 
numbers of QALYs to be achieved. Organ dysfunction measured by the Sequential Organ 
Failure Assessment (SOFA) score at 48 hours after repair of RAAA was the strongest predictor 
of death (AUC 0.79 (95% CI 0.70–0.89)).  
 
Conclusion: Surgery of RAAA is a life-saving and cost-effective procedure. The centralisation 
of vascular emergencies improved the outcome of RAAA patients; mortality due to RAAA 
decreased at all measured levels. If the level of vascular or emergency services are analysed, it is 
mandatory to analyse the fate of all patients admitted alive to hospital, not only the patients 
selected for operative treatment. The survivors had a good QoL after RAAA, and successful 
repair of RAAA resulted in a mean 4.1 QALYs. Predictive models can be used on individual 
level only to provide supplementary information for clinical decision-making due to their 
moderate discriminatory value. These results support an active operation policy, as there is no 
reliable measure to predict the outcome after RAAA.  
 




This thesis is based on the following original articles. The studies will be referred to in the text 
by their Roman numerals. 
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ABBREVIATIONS AND DEFINITIONS 
 
 
AAA   Abdominal aortic aneurysm 
APACHE II   Acute Physiologic and Chronic Health Evaluation 
AUC   Area Under the (ROC) Curve  
ECG   Electrocardiograph 
EQ-5D   EuroQol 5 Dimensions 
EVAR    Endovascular aneurysm repair 
GAS   Glasgow Aneurysm Score 
ICU   Intensive care unit 
POSSUM The Physiological and Operative Severity Score  
for the enUmeration of Mortality and morbidity 
P-POSSUM    Portsmouth POSSUM 
V-POSSUM    Vascular POSSUM 
QoL   Quality of life 
QALY   Quality-adjusted life year 
RAAA   Ruptured abdominal aortic aneurysm 
ROC curve   Receiver operating characteristic curve 
SF-36   Medical Outcomes Study Short-form 36-item survey 
SOFA   Sequential Organ Failure Assessment 
VBHOM Vascular Biochemistry and Haematology  
Outcome Models 
 
30-day operative mortality  30-day mortality of operated RAAA patients  
Operative hospital mortality Mortality of operated RAAA patients during  
the same hospitalisation irrespective of its length 
Hospital mortality Mortality of all RAAA patients admitted alive to 
hospital irrespective of the length of hospitalisation 
Overall mortality Mortality of all RAAA patients including RAAA  
deaths outside hospital  
 
 




A rupture of the abdominal aortic aneurysm (AAA) is always a surgical emergency situation. 
AAA is often asymptomatic unless and until it ruptures. Symptoms of rupture are abdominal 
pain, back pain, nausea, fainting, or loss of consciousness (Bengtsson and Bergqvist 1993). 
Patients may have several symptoms, and various other symptoms are described as well. The 
purpose of the present study was to evaluate the outcomes of ruptured abdominal aortic 
aneurysm (RAAA), especially mortality, its predictors, and quality of life.      
 
The most commonly used definition of AAA is aortic diameter of 3.0 cm or more (McGregor et 
al. 1975). Asymptomatic aneurysms are in many cases detected by abdominal ultrasonography 
done for some other medical reason. The prevalence of AAA was 4.9% among 65–74-year old 
men according to a population-based screening study, The Multicentre Aneurysm Screening 
Study (MASS) in the UK (Ashton et al. 2002). Based on the same study, the prevalence of large 
aneurysms, diameter more than 5.0 cm, was 0.6%. In men, AAA was uncommon before the age 
of 55 years, but its prevalence increased rapidly, reaching a peak (5.9%) at the age of 80 years 
(Bengtsson et al. 1992). AAA was 2–4 times more common in men than in women, in whom 
AAA was detected about 15 years later than in men, reaching a peak (4.5%) at age over 90 years 
(Bengtsson et al. 1992). 
 
Johnston et al. (1991) classified arterial aneurysms as degenerative, inflammatory, mycotic, 
mechanical, traumatic, and anastomotic aneurysms, as well as aneurysms associated with 
congenital connective tissue disorders (Ehler-Danlos, Marfan syndrome). Degenerative AAA is 
the most common type with unknown etiology, whereas there are well-known risk factors for 
AAA. Age, smoking, male gender, and family history of AAA are reported to be independent 
risk factors. Hypertension, atherosclerosis, and hypercholesterolemia are controversial risk 
factors (Singh et al. 2001, Wanhainen et al. 2005). Singh et al. reported that smoking increased 
the risk of AAA 6–7 times when current smokers were compared to non-smokers (Singh et al. 
2001).  
 
Elective surgery is indicated when the risk for aneurysm rupture is clearly higher than operative 
mortality. The maximum diameter of the AAA is the most important indicator for the risk of 
rupture (Darling et al. 1977). Current accepted thresholds for elective treatment of AAA are: 
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AAA diameter 5.5 cm or more, growth rate over 1.0 cm in a year, or symptoms caused by AAA. 
Among women the threshold may be lower, and 5.0 cm diameter has been suggested, althoug 
clear evidence for this does not exist (Brown et al. 2003). The mortality of elective open repair of 
AAA is 4-5% (Heller et al. 2000, Dueck et al. 2004b, Rigberg et al. 2006).  
 
Endovascular repair of AAA is a less invasive procedure which is used in both elective and 
emergency repair. The Dutch Randomized Endovascular Aneurysm Management (DREAM) and 
the Endovascular Aneurysm Repair (EVAR) Trial 1 compared endovascular repair with open 
repair of AAA (Blankensteijn et al. 2005, EVAR trial participants 2005a). Both trials reported 
lower 30-day mortality in the endovascular group, but after two years the survival rates for 
endovascular and open repair were equalized (Blankensteijn et al. 2005). Four years after 
randomisation, the EVAR 1 Trial demonstrated a 3% reduction in aneurysm-related mortality 
after endovascular repair. However, all-cause mortality was equal in both groups (EVAR trial 
participants 2005a). The EVAR Trial 2 compared endovascular repair with best-medical 
treatment in patients unfit for open repair of AAA (EVAR trial participants 2005b). After four 
years of follow-up the overall mortality rates were high in both groups, 66% after endovascular 
repair and 62% in the non-intervention group, with no statistical difference between the groups. 
This might be due to the fact that only patients unfit for surgery were included in the EVAR 2 
Trial.        
 
RAAA causes 1 to 2% of all deaths in industrialized countries (St Leger et al. 1996). In Finland 
there were 270 RAAA deaths in 2004 according to the cause of death registry of Statistics 
Finland. In the future the number of RAAAs will increase as the number of aged persons is 
growing.    
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REVIEW OF THE LITERATURE 
 
 
TYPES OF RUPTURE 
 
Rupture of AAA can occur in a number of ways: most frequently as a closed rupture with the 
formation of a retroperitoneal haematoma, a free rupture in to the intraperitoneal cavity, with the 
site of perforation usually in the anterior wall, or a rupture in to an adjacent organ; vena cava or 
duodenum (Szilagyi 1982).   
 
The site of the aneurysm rupture varies and affects the outcome (Golledge et al. 1999). The 
aneurysm diameter was greatest in the middle third of the infrarenal aorta where most aneurysm 
ruptures occurred. In transverse dimensions, the rupture site was distributed all around the 
aneurysm. The site of aneurysm rupture in the transverse dimension was closely related with 
retroperitoneal haematoma, which occurred in 98% of the cases. The autopsy study, based on 
118 non-operated RAAAs, revealed intraperitoneal rupture in 15% of the cases (Darling et al. 
1977). Golledge et al. (1999) reported free intraperitoneal rupture in 22% of the cases. Gloviczki 
et al. (1992) reported that 69%  (146/213) of the operated RAAA patients had retroperitoneal 
staining or haematoma, 31% had free intraperitoneal rupture, and 2% aortocaval fistula. 
Aortoduodenal fistula is unusual especially before aortic reconstruction (Miani et al. 1984).  
 
Contained RAAA is uncommon (2.8–3.3%). The rupture site has most commonly been reported 
to be posterior, in 63% in the study of Sterpetti et al. (1990) and 85% in the study of Bonamigo 
et al. (2006) of the cases. Haematoma is chronically contained by the surrounding structures such 
as psoas muscle, and anterior and posterior renal fascia.       
 
 




The incidence of RAAA is increasing or has not changed over the past few decades (Mealy and 
Salman 1988, Thomas and Stewart 1988, Drott et al. 1992, Bengtsson and Bergqvist 1993, 
Reitsma et al. 1996, Katz et al. 1997, Choksy et al. 1999, Heller et al. 2000, Heikkinen et al. 
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2002). In Finland the incidence of RAAA was 6.1/100 000 (Kantonen et al. 1999b) and  
6.3/100 000 in the well-defined geographic region of Pirkanmaa (Heikkinen et al. 2002). Similar 
incidence rates of 5.6-6.9/100 000 have been reported in the Scandinavian countries (Johansson 
and Swedenborg 1986, Drott et al. 1992, Bengtsson and Bergqvist 1993). Bengtsson et al. (1993) 
estimated that incidence would increase from 5.6/100 000 to 6.3/100 000 assuming the number 
of not autopsied included. The incidence rate in the UK was 8/100 000 (Basnyat et al. 1999). In 
the USA Heller et al. (2000) reported unchanged age- and population adjusted incidences of 
6.6/100 000 to 16.3/100 000 over the past two decades, including the roughly estimated number 
of RAAA patients dying outside hospital. Recently Dillavou et al. (2006) reported decreased 
incidence of RAAA during 1994–2003 in the USA. In their series, the incidence of RAAA 
surgery for patients older than 65 years declined from 18.7/100 000 (1994) to 13.6/ 100 000 
(2003). Endovascular repair for elderly patients who are at a high risk of rupture may be one 
reason for the decreased number of ruptures in the recent years. The reported RAAA incidences 
vary due to a multitude of data retrieval methods, sample selection, age, sex, and autopsy rate.   
 
Men have a 2–4-fold RAAA incidence compared to women (Mealy and Salman 1988, Bengtsson 
and Bergqvist 1993, Reitsma et al. 1996, Katz et al. 1997, Choksy et al. 1999). In Malmö, 
Sweden, Swedish men had a mean incidence of 8.4/100 000 and women 3.0/100 000 (Bengtsson 
and Bergqvist 1993), and in Pirkanmaa, Finland, Finnish men 10.5/100 000 and women  
2.7/100 000 (Heikkinen et al. 2002). Katz et al. (1997) reported for hospitalised patients over  
50 years of age in the USA an incidence of 22.6/100 000 for men and 4.5/100 000 for women. 
Men under 50 years of age had an incidence of 0.1/100 000 (Bengtsson and Bergqvist 1993) and 
those under 65 years 2.1/100 000 (Heikkinen et al. 2002). Heikkinen et al. (2002) reported an 
incidence of 35.5/100 000 for the population aged 65 years and over and the age-specific 
incidence was highest in men over 80 years (138.9/100 000). Bengtsson et al. (1993) found the 
highest incidence in male patients older than 80 years (118/100 000). However, the largest 
number of RAAAs in relation to the number of deaths was observed among 70 to 80-year old 
men.   
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Growth rate and risk of rupture 
 
The current standard for estimating the risk of rupture is the maximum AAA diameter (Darling 
et al. 1977). 25% of men and 15% of women may be prone to aortic dilatation (Wilmink et al. 
1998). Of all AAAs, 13% will eventually rupture (Bengtsson et al. 1992). The risk of rupture 
increases with the increasing diameter of aneurysm. AAA grows exponentially, and the growth 
rate is faster in large aneurysms. Based on the results of The UK Small Aneurysm Trial, the 
annual rupture rate of AAA of diameter 4.0 to 5.5 cm is 1% (The UK Small Aneurysm Trial 
participants 1998). After the AAA diameter reaches 5.0–6.0 cm, the risk of rupture increases 
(Nevitt et al. 1989, Vardulaki et al. 1998, Lederle et al. 2002).  
 
Vardulaki et al. (1998) used data collected from two prospective population-based screening 
studies in the UK. Within one year after AAA detection, the risk of rupture for AAA with initial 
diameter of 3.0 ranged from 0.2–0.4% depending on the diameter at first follow-up, for  
a diameter of 4.0 cm 0.8–1.1%, for 4.5 cm 1.2–2.1%, and for 5.0 cm 2.2–3.6%, respectively 
(Table 1). For AAA with an initial diameter <5 cm, the probability that the diameter will reach  
6 cm within three years or will rupture, is very small. Based on the same study, the risk that an 
aneurysm of 5.5 cm would rupture within 5 years was estimated to be 31.3% (Vardulaki et al. 
1998).  
 
Lederle et al. (2002) reported results of a prospective cohort of 198 patients with large AAA 
(>5.5 cm) for whom elective repair was not planned due to poor medical condition or patient 
refusal. Within one year, if the initial diameter was 5.5–5.9 cm, the risk of rupture was 9.4%, if 
the diameter was 6.0-6.9 cm the risk was 10.2%, and if the diameter was >7.0 cm the risk was 
32.5% (Table 1). They also reported that after secondary measurement when the AAA reached  
a diameter of at least 8 cm, the risk of rupture was 36.4% during the first year. For large 
aneurysms (>5.5 cm) the AAA growth rate was median 0.43 cm per year (interquartile range, 
0.08–0.79 cm per year) (Lederle et al. 2002). The growth rate of small aneurysms was slower: 
with AAA diameter 3.0–3.9 cm the mean growth was 0.18 cm per year; 4.0–4.4 cm 0.23 cm; 
4.5–4.9 cm 0.34 cm, respectively (Solberg et al. 2005). Although a large AAA will eventually 
rupture, 62% of the deaths were due to causes other than RAAA, such as cardiovascular diseases 
(Lederle et al. 2002). Law et al. (1994) estimated the AAA rupture risk using data from 13 
different reports (Table 1). Studies concerning the risk of rupture of large aneurysms are based 
on autopsy reports or patients unfit for surgery studies, so the number of patients is small.  
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Table 1. Studies focussing on the annual risk of rupture of AAA.  
 
  Risk of rupture (%)  
AAA diameter (cm) Law et al.* Vardulaki et al. Lederle et al. 
<3.0 0 NA NA 
3.0–3.9 0.4 0.2 NA 
4.0–4.4 1.1 0.8 NA 
4.5–4.9 1.1 1.4 NA 
5.0–5.4 3.3 2.5 NA 
5.5–5.9 3.3 NA 9.4 
6.0–6.4 9.4 NA 10.2 
6.5–6.9 9.4 NA 19.1 
>7.0 24.5 NA 32.5 
 
NA = not available; * = used 1 cm discrimination 
 
 
Women have a smaller aortic diameter than men (Sonesson et al. 1993). Solberg et al. (2005) 
recently reported an increased growth rate of AAA in women; the mean growth rate for women 
was 0.243 cm per year compared with 0.165 cm for men. The current threshold for elective 
operative treatment is nevertheless similar for both genders. Thus women are at a 3–4-fold 
higher risk for RAAA rupture than men (Brown and Powell 1999, Brown et al. 2003) and a 
lower threshold should therefore be considered (Table 2).   
 
Table 2. The annual risk of rupture of AAA according to gender and diameter, data based on Brown et al. 2003. 
 
AAA diameter, cm Risk of rupture (%) Relative risk (95% CI) 
Men, 5.0-5.9 1.0 1.0 
Women, 5.0–5.9 3.9 4.0 (1.2,13.0) 
Men, >6.0 14.1 14.3 (5.9,34.5) 
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Risk factors 
 
Risk factors associated with rupture in the study cohort based on The UK Small Aneurysm Trial 
were female sex (3.0 Adjusted Hazard Ratio (95% Confidence Interval 1.99–4.53)), larger initial 
aneurysm diameter (2.94 (2.49–3.48) per cm), reduced lung function (FEV1 0.62 (0.45–0.86)  
per L), smoking (never smoked 0.65 (0.27–1.53)), and hypertension (1.02 (1.00–1.03)  
per mmHg) (Brown and Powell 1999). In addition to initial diameter risk factors affecting the 
expansion rate of AAA included age, smoking, and hypertension (Cronenwett et al. 1990, Chang 
et al. 1997, Tornwall et al. 2001). Vardulaki et al. (1998), however, did not find hypertension to 
increase the growth rate of AAA. A recent population-based study showed that risk factors 
associated with the development of large AAA were male gender, smoking, physical inactivity, 
and high serum total cholesterol (Lindblad et al. 2005). 
 
Other parameters than maximum diameter have been proposed as potential predictors of AAA 
rupture. The AAA ruptures when the strength of the aortic wall is insufficient to sustain the 
stress on it. Taking into consideration both the stress and strength of the wall the identification of 
patients with AAA who are at highest risk for rupture could be improved (Vorp and Vande Geest 
2005). Fillinger et al. (2003) demonstrated that elevated peak wall stress was superior to AAA 
diameter for predicting rupture risk. Peak wall stress was analysed with three-dimensional (3D) 
computed tomography reconstructions. Also Hall et al. (2000) demonstrated that wall stress 
predicted AAA rupture. They calculated the wall tension from computer tomography images 
using the Law of Laplace, which assumes that AAA is a symmetric cylinder. However, the 
actual anatomic characteristics of AAA reflected rupture risk; RAAAs were less tortuous with 
greater cross-sectional diameter asymmetry than electively evaluated AAAs (Fillinger et al. 
2004).  
 
A weakening of the aortic wall was associated with rupture (Di Martino et al. 2006) but little is 
known about the mechanism involved (Vorp and Vande Geest 2005). Thickening of the 
intraluminar thrombus caused local hypoxia in the aneurysm wall, and could lead to regional 
wall weakening (Vorp et al. 2001). An inflammatory reaction in the aortic wall causes 
degeneration and remodelling, and an imbalance between them favouring degeneration, which 
may lead to rupture (Petersen 2003). A reduction of elastin-derived peptides could possible 
indicate impending rupture, as could higher levels of matrix metalloproteinase MMP-9 (Petersen 
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et al. 2001, Petersen et al. 2002). Although all these factors have been shown to predict AAA 
rupture, measuring the wall stress and strength is still used only in laboratory settings.  
 
The reason for AAA ruptures at any particular time is unknown. Studies on seasonal variation 
have revealed a peak in wintertime (Ballaro et al. 1998, Bown et al. 2003), and low atmospheric 
pressure has also been associated with rupture (Bown et al. 2003, Harkin et al. 2005).   
 
 




The natural outcome of RAAA is death. Surgery is the only treatment that can save the life of 
RAAA patient. Without operative treatment, survival time is a few hours; only 2 out of 69 
patients survived 6 days (Lloyd et al. 2004, Boyle et al. 2005). In very rare cases it has been 
possible to survive after RAAA without operative treatment (Christenson et al. 1984, Sundhagen 
et al. 2006). A small number of studies or case reports have demonstrated the outcomes of 
contained rupture (Table 3) (Christenson et al. 1984, Sterpetti et al. 1990, Defraigne et al. 2001, 
Dorrucci et al. 2001, Al-Koteesh et al. 2005, Bonamigo et al. 2006, Sundhagen et al. 2006). The 
symptoms of these patients were less acute or even missing, and operative treatment was 
performed weeks after the probable time of the initial symptoms in patients with contained 
RAAA (Sterpetti et al. 1990, Defraigne et al. 2001).    
 
Table 3. Studies on contained RAAAs.  
 





Bonamigo et al. 2006 13 13 (100) NA 1 (8) 
Sundhagen et al. 2006 1 0 (0)  0 
Al-Koteesh et al. 2005 1 1 (100) Months 0 
Dorrucci et al. 2001 1 1 (100) 6 weeks 0 
Defraigne et al. 2001 5 5 (100) Mean 6 weeks 1 (20) 
Sterpetti et al. 1990 16 13 (100) Mean 17 weeks 1 (6) 









Roughly half of the RAAA patients died before reaching hospital, and the other half underwent 
surgery. Half of the operated patients survived, whereas overall mortality was as high as 70-90% 
(Thomas and Stewart 1988, Drott et al. 1992, Bengtsson and Bergqvist 1993, Kantonen et al. 





In assessing the outcome of surgery, the most common monitoring interval is 30-day mortality 
(Russell et al. 2003). The mortality figures for RAAA, however, vary considerably, depending 
on the patients included in a study (Callam et al. 1991). A varying number of the RAAA patients 
who are alive on arrival to the emergency room are selected for surgery. The mortality figures 
are affected by the inclusion or exclusion of the patients selected to undergo surgery, of those 
intended to undergo surgery but who die before its start or during it as well as of deaths outside 
the primary surgical unit. The 30-day mortality alone is not adequate to reflect the true surgical 
mortality. In-hospital mortality should include deaths also after 30 days, but before hospital 
discharge, and this should be viewed as hospital mortality. Stenbaek et al. (2004) used 60-day 
operative mortality because deaths between day 30 and 60 were related to the surgical procedure. 
Thus 60-day operative mortality reflected surgically related operative hospital mortality better 
than did crude 30-day operative mortality. An unanswered question is how to include in the 
analyses all these deaths during the whole hospitalisation period, including further treatment at  
a lower care level.  
 
If 30-day mortality or hospital mortality include only operated patients, it should be called 
operative mortality. The operative mortality rate overlooks the actual hospital mortality and does 
not reflect the vascular service of the area. The proportion of RAAA patients who arrive alive at 
the hospital, but who are considered unfit for surgery, varied from 7–43% (weighted mean 24%) 
in numerious series (Table 4) (Hardman et al. 1996, Bradbury et al. 1997, Barry et al. 1998, 
Semmens et al. 1998, Adam et al. 1999, Basnyat et al. 1999, Evans et al. 2000, Kantonen et al. 
1999b, Noel et al. 2001, Heikkinen et al. 2002, Neary et al. 2003, Bown et al. 2004, Dueck et al. 
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2004a, Tambyraja et al. 2005d). In the Finnvasc study Kantonen et al. found huge variations in 
the selection criteria between hospitals in Finland, resulting in the exclusion of 12–63% RAAA 
patients from emergency repair (Kantonen et al. 1999b). In the recent Medicare data from the 
USA, 98% of the patients being 65 years or older, 28 859 RAAAs were recorded, of whom 8 669 
(30%) were not operated, 19 420 underwent open repair, and 770 endovascular repair (McKinsey 
et al. 2006). Contraindications for operative treatment were age, co-morbidities, malignancy with 
short life expectancy, poor general status, and refusal of surgery (Bengtsson and Bergqvist 1993, 
Hardman et al. 1996, Heikkinen et al. 2002). Hewin et al. (1998) reported the factors influencing 
the decision of the vascular surgeon not to operate some of the RAAA patients. Almost every 
vascular surgeon (97%) (313/323) decided not to operate on selected patients: age >80 years 
influenced 77% of the decisions seldom or never to operate a RAAA patient. A severe 
neurological disease and cardiac arrest were also influencing factors. 
 
The weighted mean operative mortality rate for RAAA was 42% (range 29–64%) in the recent 
studies (Table 4) (Chen et al. 1996, Hardman et al. 1996, Rutledge et al. 1996, Bradbury et al. 
1997, Koskas and Kieffer 1997, Barry et al. 1998, Dardik et al. 1998, Semmens et al. 1998, van 
Dongen et al. 1998, Adam et al. 1999, Basnyat et al. 1999, Kantonen et al. 1999b, Sasaki et al. 
1999, Evans et al. 2000, Noel et al. 2001, Heikkinen et al. 2002, Neary et al. 2003, Roddy et al. 
2003, Bown et al. 2004, Dueck et al. 2004a, Stenbaek et al. 2004, Davidovic et al. 2005, 
Hadjianastassiou et al. 2005, Tambyraja et al. 2005d, Visser et al. 2005, Rigberg et al. 2006). 
Table 4 presents the 30-day operative mortality, operative hospital, and hospital mortality rates 
after RAAA during the past 10 years in the series of more than 150 RAAA patients. 
Interestingly, the total weighted mean mortality rates of 30-day operative and operative hospital 
mortality did not differ, but this was due to the fact that the mortality rates were collected from 
different publications. Indisputable RAAA deaths have been reported between 30-day and 
discharge; the weighted mean from four series was 1.7%. Omitting deaths that occurs after  
30 days, and the high percentage of non-operated patients with a lower mortality rate, may lower 
the publication threshold. There are a number of reasons for unintentional or intentional data 
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Table 4. Literature review of mortality after ruptured abdominal aortic aneurysm. 
 













Rigberg et al. 2006 2628 Excl. 45 46 NA 
Davidovic et al. 2005 406 Excl. 48  NA 
Hadjianastassiou et al. 2005 605 Excl.  47 NA 
Tambyraja et al. 2005 378 21  44 56 
Visser et al. 2005 5593 Excl.  41 NA 
Bown et al. 2004 222 18 46 48 57 
Dueck et al. 2004 3570 27 41  53 
Stenbaek et al. 2004 249 Excl. 51 57* NA 
Neary et al. 2003 232 18 54  63 
Roddy et al. 2003 323 Excl. 29  NA 
Heikkinen et al. 2002 221 13 51  63 
Noel et al. 2001 413 7 37 41 45 
Evans et al. 2000 692 15  34 44 
Adam et al. 1999 381 17 41  51 
Basnyat et al. 1999 233 43 64  79 
Kantonen et al. 1999 454 31  54 68 
Sasaki et al. 1999 183 Excl.  54 NA 
Barry et al. 1998 258 7  43 47 
Dardik et al. 1998 527 Excl. 47  NA 
Semmens et al. 1998 494 43 36  63 
Van Dongen et al. 1998 309 Excl.  25 NA 
Bradbury et al. 1997 632 19  35 47 
Koskas et al. 1997 158 Excl. 53  NA 
Chen et al. 1996 157 Excl. 46  NA 
Hardman et al. 1996 175 12  39 46 
Rutledge et al. 1996 1480 Excl.   55 
Weighted mean (95% CI)  20973 24 (17–31) 42 (38–46) 42 (37–47) 54 (49–59) 
 
Excl. = excluded from the study; NA = not available; * = 60-day operative mortality 
 
 
Registry data are vulnerable to omissions (Lepäntalo et al. 1994, Kantonen et al. 1997). In 
Finland, the operative hospital mortality rate was 49% and 54%, based on the data of the 
vascular registry and the data of Statistics Finland, respectively (Kantonen et al. 1999b). 
Different mortality rates indicate that data escapes from the registries. According to the same 
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report, hospital mortality was 68% in 1991–1994. Reviews and reports which used data from 
random, stratified samples representing discharges from hospitals are not included in Table 4 
(Heller et al. 2000, Hallin et al. 2001, Bown et al. 2002, Dillavou et al. 2006). Bown et al. (2002) 
reported an overall operative mortality rate of 48% in a meta-analysis of RAAA in 1955–1998. 
A gradual reduction over time, approximately 3.5% per decade, was observed. In  
a literature review covering the years 1985–1997 Hallin et al. (2001) reported a 30-day operative 
mortality rate of 47% with no improvement over the years. Similarly, Heller et al. (2000) 
reported an operative mortality rate of 46% on a national level in the USA, with no improvement 
over the years 1979–1997. A recent study from the USA over the years 1994–2003 reported  
a decrease in the incidence of RAAA surgery, but 30-day operative mortality remained 
unchanged (Dillavou et al. 2006). The extensive Medicare data also from the USA revealed an 
operative mortality of 54% for open repair of RAAA, of 61% for endovascular repair, and  
a hospital mortality of 68% including RAAA patients unfit for surgery (McKinsey et al. 2006).   
 
Mortality in the postoperative year is an important measure of outcome (Rigberg et al. 2006). In 
a large group of RAAA patients (n=2628) the 30-day operative mortality was 45.1%, hospital 
mortality 45.7%, and 1-year mortality 53.5%. The mortality was 8.4% between days 31 to 365 
after repair of RAAA. Dueck et al. (2004b) reported a 30-day operative mortality of 40% and  
a 1-year mortality of 48% after repair of RAAA. Mortality remained unchanged over time 
(1993–1999). These studies on mortality during the first year after RAAA did not describe the 
discharge status of the patients, although the proportion of patients discharged home, to nursing 
homes and further institutional care would be of great interest.  
 
 
Volume outcome associations 
 
The type of hospital influenced mortality. High-volume hospitals had lower mortality rates than 
low-volume hospitals (Birkmeyer et al. 2003). Comparison of the reports is difficult because the 
definition of hospital volume differs. Rigberg et al. (2006) demonstrated an increased operative 
mortality associated with low-volume hospitals for patients with RAAA. Low-volume was 
defined as <16 cases/year (high-volume >32.5 cases/year, medium-volume between these two). 
Dimick et al. (2002) used the term high-volume hospital when the number of elective AAA 
procedures was more than 30 per year, and found lower operative mortality among these 
hospitals. Heller et al. (2000) reported hospital bed number <500 as a predictor for operative 
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mortality after RAAA based on a large database. Rutledge et al. (1996) found better survival 
after surgery in hospitals with a bed number >100. On the contrary, Visser et al. (2005) reported 
better survival in hospitals with <400 beds or in university hospitals, in the Netherlands, but the 
number of patients unfit for surgery was not available. Based on an other study in the 
Netherlands, 34% of admitted RAAA patients did not undergo surgery in 1992 (Reitsma et al. 
1996).  
 
Some studies have shown that hospital volume has no effect on mortality, but that high-volume 
surgeons or vascular surgeons had better outcome rates than general surgeons (Ouriel et al. 1990, 
Dardik et al. 1998, Dueck et al. 2004c). Basnyat et al. (1999) found operative mortality to be 
similar between vascular surgeons and non-vascular surgeons, but vascular surgeons turned 
down significantly fewer patients.  
 
In Finland high-volume hospitals (>15 elective AAA procedures per year) had lower overall 
hospital mortality than low-volume hospitals, indicating that more RAAA patients were defined 
as unfit for surgery in low-volume hospitals (Kantonen et al. 1999b). Consequently, operative 
mortality did not differ between high-volume and low-volume hospitals. This clearly 
demonstrated that there is bias related to operative mortality, due to the different rates of 
omission.        
 
The risk related to transportation has been debated due to the trend towards specialisation and 
centralisation in vascular surgery. The question has been whether to transport the patient to the 
nearest surgical unit or to a vascular centre. Dueck et al. (2004c) reported that distance was not 
associated with mortality after RAAA. Similar results were reported in Finland (Kantonen et al. 
1999a). Adam et al. (1999) examined RAAA patient transferral between hospitals. Transferring 
patients from other units to a vascular centre did not affect mortality either. They nevertheless 





Long-term survival is as important measure of outcome as hospital mortality, but it is 
infrequently reported. The population screening for AAA is increasing, and endovascular repair 
for RAAA is deemed an acceptable treatment (Greco et al. 2006, Peppelenbosch et al. 2006). 
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Long-term survival after any given type of repair of RAAA is especially important to allow 
comparison between different treatment methods. 
 
Data on long-term survival of survivors after RAAA have caused controversy. The long-term 
survival of patients after RAAA has been compared with that of a group treated with elective 
repair, and with an age- and sex-adjusted population. Dueck et al. (2004b) showed no difference 
on long-term survival for 30-day survivors after RAAA compared to a group of elective repair of 
AAA in a large study (n=2280). Similar results have been reported previously (Rohrer et al. 
1988, Stonebridge et al. 1993, Soisalon-Soininen et al. 1995). Contradictory results with worse 
long-term survival have been reported by others (Johnston 1994b, Cho et al. 1998). Cho et al. 
(1998) reported cumulative survival rates of 86%, 64%, and 33% after successful repair of 
RAAA at 1, 5, and 10 years, respectively. After elective repair, the survival rates at the same 
intervals were 97%, 74%, and 43%, respectively, and the survival rates of the general population 
were 95%, 75%, and 52%, respectively. Based on the previous reports, the range of crude five-
year survival after RAAA is 40–60% (Rohrer et al. 1988, Soisalon-Soininen et al. 1995, Cho et 
al. 1998, Evans et al. 1999, Dueck et al. 2004b). 
 
Several studies have reported long-term survival after repair of RAAA equal to that of the age- 
and sex-adjusted population (Rohrer et al. 1988, Stonebridge et al. 1993, Hinterseher et al. 
2004). Others have reported poorer outcomes in similar comparisons (Cho et al. 1998, van 
Dongen et al. 1998).  
      
The life expectancy of elderly patients after RAAA was similar to that of an age- and sex-
adjusted control population in previous studies (Evans et al. 1999, Aune et al. 2004, Stenbaek et 
al. 2004). Norman et al. reported even better survival for over 80-year-olds than expected life 
expectancy, although this group included elective AAA patients (Norman et al. 1998). Van 
Dongen et al. (1998) found worse long-term survival for RAAA patients older than 70 years 
compared to the general population. For patients age over 80 years, 1-year mortality was >70%; 
this was worse compared to the general population in the age group of 81–90 years (n=514) but 
better in the age group of 91–100 (n=59) (Rigberg et al. 2006).  
 
The influence of gender is also ambiguous. Women displayed worse long-term survival than 
either the elective surgery group or the age- and sex-adjusted population (Norman et al. 1998, 
Stenbaek et al. 2004). After five years 30% of women were alive compared to 50% of men after 
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repair of RAAA (Norman et al. 1998). The reason for the worse outcome is not clear, but the 
main cause of death was related to atherosclerotic diseases after discharge (Norman et al. 1998). 
On the contrary, gender did not influence long-term survival (Johnston 1994a, Evans et al. 
2000). 
 
It has been suggested that the relative survival ratio (Norman et al. 1998) or standardised 
mortality ratio (Stenbaek et al. 2004) should be used to allow a proper comparison. In general, 
women have a longer life expectancy than men, but after RAAA this advantage disappears. The 
5-year relative mortality after repair of RAAA was 1.04 for men and 1.92 for women (Norman et 
al. 1998). Stenbaek et al. (2004) reported a 1.96 standardised mortality ratio for RAAA patients 
compared with the normal population, and Van Dongen et al. (1998) reported a standardised 
mortality ratio of 2.1 (95% CI 1.7–2.5) after RAAA.  
 
 
Quality of life 
 
The outcome of surgery is often measured by mortality and morbidity, but these measures fail to 
take the patient’s perspective of outcome into account. QoL assessment has become increasingly 
important in many fields of medicine, also in vascular surgery. Health-related QoL measures are 
divided into two groups: generic and disease-specific measures. Generic measures are designed 
for any disease or health problem in any population sample, while disease-specific measures 
focus on aspects of health that are important to specific health problems (Patrick and Deyo 
1989). 
 
A few studies have focused on QoL assessment after RAAA (Rohrer et al. 1988, Currie et al. 
1992, Magee et al. 1992, Hennessy et al. 1998, Bohmer et al. 1999, Joseph et al. 2002, Piper et 
al. 2003, Hinterseher et al. 2004, Tambyraja et al. 2005b). The measures used were generic, and 
not necessarily validated, and the number of patients was in general small. These studies 
provided results that were mainly equal with those of the age- and sex-adjusted general 
population or patients undergoing elective repair of AAA (Table 5).  
 
Self-designed questionnaires were used to assess QoL (Currie et al. 1992, Piper et al. 2003). 
Currie et al. (1992) designed a QoL questionnaire comprising three parts. The questionnaire was 
completed in the patient’s home by the interviewer, and the results of rupture and elective AAA 
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patients were compared with age- and sex- matched control subjects chosen by the survivors’ 
general practitioner. The QoL of the patients over 80-years old was comparable to that of the 
control subjects, but the sample consisted of only seven patients. Piper et al. (2003) asked 
survivors after RAAA to rate their recovery compared to their preoperative status, and assigned a 
quality score of one to four describing coping with daily routines. After a median of 45 months 
follow-up time, the RAAA patients reported their QoL to be equal to the preoperative status 
(n=39). 
 
One of the earliest QoL studies on RAAA by Rohrer et al. (1998) used a modified version of 
Self-evaluation of Life Function Scale and compared the results with patients undergoing 
elective repair (n=29). The validation of this modified version was uncertain. Magee et al. (1992) 
and Hennessy et al. (1998) used a validated Rosser index classification. Hennessy et al. (1998) 
reported a QoL equal to that of elective controls (n=14), and Magee et al. (1992) reported 
impaired QoL after RAAA (n=45). The QoL -index was lower postoperatively than 
preoperatively. Patients undergoing elective repair, on the other hand, had an improved QoL 
index after repair (Magee et al. 1992). The rupture group and elective group were not age-
matched; the RAAA patients were older than those undergoing elective surgery.   
 
The latest QoL studies have used the validated SF-36 measure (Ware and Sherbourne 1992). 
Comparison of RAAA survivors with the norms of age- and sex-adjusted population revealed no 
significant differences between these groups (n=28) (Bohmer et al. 1999). Joseph et al. (2002) 
reported the same or even better QoL compared to norms (n=26). In their recent study, 
Tambyraja et al. (2005b) reported equal QoL after emergency and elective repair of RAAA  
(n=30). When comparison was made with the norms of an age- and sex-adjusted population, 
RAAA patients had worse outcomes in two out of eight health domains, i.e. role limitations due 
to physical and emotional problems. The value of this study was the fixed follow-up time, as the 
QoL questionnaire was sent to the survivors six months after surgery of RAAA. Although, six 
months was usually the time for patients with an elective AAA operation to regain their 
preoperative health-related levels, it may nevertheless be too short to recover after major surgery 
of RAAA (Perkins et al. 1998). Critically ill ICU patients (including 40 emergency surgery cases 
of any nature) had a worse QoL one year after intensive care than the age- and sex-adjusted 
population (Pettilä et al. 2000).        
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Hinterseher et al. (2004) used the WHO-QOL-BREF test because of its international 
comparability and its brevity. They considered the SF-36 questionnaire to be lengthy, although it 
is more widely used. The QoL was equal in all five health domains compared to the age- and 
sex-adjusted control population.   
 
All previous QoL studies are retrospective with different follow-up times, except the one by 
Tambyraja et al. (2005b). Furthermore, preoperative QoL assessment is not feasible nor even 
possible after RAAA. In addition, a small sample size is sensitive to bias and may reflect an 
absence of differences. 
 




Year N Measure Findings in QoL 
Tambyraja et al. 2005 30 SF-36 Good QoL, equal to 
elective group but 
worse than norms 
Hinterseher et al. 2004 24 WHO-QOL-BREF-test QoL equal to the 
general population 
 
Piper et al. 2003 39 Authors’ own 
questionnaire 
QoL equal to 
preoperative status 
 
Joseph et al. 2002 26 SF-36 Equal or better QoL 
compared to norms 
 
Bohmer et al. 1999 28 SF-36 QoL equal to norms 
 
Hennessy et al. 1998 14 Rosser index Good QoL, equal to 
elective group 
 




QoL equal to normal 
subjects 
 
Magee et al. 1992 45 Rosser index Impaired QoL 
 
Rohrer et al. 1988 29 Modified Self-
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SF-36 
 
The Medical Outcomes Study Short-form 36-item survey (SF-36) is the most widely used and 
validated generic health-related QoL measure (Ware and Sherbourne 1992, Garratt et al. 2002). 
The SF-36 was found to be valid and reliable for use in a vascular setting and was recommended 
for QoL assessment in vascular patients (Beattie et al. 1997). The RAND-36 is based on the  
SF-36 measure (Hays et al. 1993) and consists of the same 36 questions that assess eight health 
domains: 1) physical functioning, 2) limitations in daily routines activities because of physical 
health problems, 3) social functioning, 4) limitations in daily routine activities because of 
emotional health problems, 5) general mental health, 6) vitality (energy and fatigue), 7) pain, and 
8) perception of general health. For each domain a score can be calculated from 0 to 100, the 
higher scores indicating better QoL (0 lowest, 100 perfect health). A validated Finnish version 
with norms of the age- and sex-matched population is available (Aalto et al. 1999).  
 
The results of the SF-36 QoL assessment after RAAA are presented in Table 5 (Bohmer et al. 





The EuroQol, EQ 5 Dimensions (EQ-5D) is a generic measure (The EuroQol Group 1990). Its 
advantage is the use of the results as a single index which allows the calculation of quality-
adjusted life years (QALY) and thus economic evaluation. The higher index indicates better 
QoL, ranging from 0 (death) to 1 (perfect health). The EQ-5D consists of five questions, defining 
five health dimensions such as mobility, self-care, usual activities, pain/discomfort, and 
anxiety/depression. The patients also assess their current health status on the Visual Analogue 
Scale (VAS), which ranges from 0 (worst imaginable health state) to 100 (best imaginable health 
state). Ohinmaa et al. have done the validation in the Finnish population (Ohinmaa and Sintonen 
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Cost-utility 
 
A quality-adjusted life year (QALY) is a measure combining the quantity and the quality of life 
(Taylor and Gerrard 2002). It is calculated by multiplying the length of life, including life 
expectancy by quality adjustment. Quality adjustment ranges from 0 (death) to 1 (alive in perfect 
health). Cost-effectiveness assesses the costs of treatment and measures the health effects of that 
treatment. Three methods have been used for economic evaluation: 1) a cost-benefit analysis, 
where the benefit is assessed only as monetary values; 2) a cost-effectiveness analysis where the 
outcome is assessed in clinically relevant scales, such as life years gained; 3) a cost-utility 
analysis, where the outcome is assessed as QALYs (Taylor and Gerrard 2002). If the net costs of 
the treatment are divided by the net effects of the treatment, it is called the cost-effectiveness 
ratio, which is usually expressed as a cost per QALY saved. QALYs allow the comparison of 
cost-effectiveness ratios between diseases and treatments. To enhance the comparability across 
health interventions, cost-effectiveness analyses are ideally based on lifetime simulations of 
related costs and quality-adjusted survival (Shepard 1999).  
 
Patel et al. (2000) used a hypothetical cohort of RAAA patients, calculating 3.4 QALYs to be 
achieved after RAAA surgery. They used estimates and calculated the costs for initial 
hospitalisation to be 22 700 € and for lifetime 28 800 € (US Dollars converted to Euros). Thus 
the cost-effectiveness ratio was 8 500 €/QALY. A mortality of 50% was used as a base-case of 
mortality. If mortality rose to a level of 80%, the cost-effectiveness ratio rose to 24 800 €/QALY. 
The impact of age was also calculated; if age and operative mortality were adjusted, the cost-
effectiveness ratio for a 95-years old RAAA patient was 47 600 €/QALY. 
 
Tang et al. (2003) calculated costs for 47 RAAA patients. They found huge variation in the costs. 
For complicated aneurysms, which by definition developed one or more dysfunction in the organ 
system needing system support, the median costs were 30 150 € and for uncomplicated 
aneurysms 9 600 € (UK Sterling converted to Euros). The median overall cost was 12 100 € and 
nearly twice that of an elective repair. Costs were calculated for RAAA patients selected for 
surgery; 8 non-operated patients were excluded from the analysis. 
 
Seiwert et al. (1995) calculated the cost of additional, adjusted life years for 119 patients 
undergoing surgery for RAAA; 6 patients were excluded from the analysis as unfit for surgery. 
In the age group of 65-69 years, 31 patients had the lowest overall mortality (22%) and they 
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consumed the greatest total costs. The mean cost for each RAAA patient was 17 900 €, but with 
successful outcome the mean cost per survivor was 32 800 € (US Dollars converted to Euros). 
The cost per additional adjusted life year was 3 200 €.  
 
Aune et al. (2004) reported the life years gained in over 80-year-olds after RAAA. The operative 
mortality was 47% (25/53). Mean survival was 2.7 years for all the patients and  
5.2 years for survivors. The over 80-year-olds gained 145 life years in total and the estimated 
cost per gained life year was 6 800 €. 
 
 
Predictors of outcome 
 
Attempts have been made to identify predictors of mortality on different levels of the treatment 
chain of RAAA patients in the hospital. Most of these studies have evaluated risk factors 
predicting 30-day or hospital mortality. The initial decision on whether to operate or not is 





Advanced age is associated with increased operative mortality after RAAA (Katz et el. 1994, 
Samy et al. 1994, Chen et al. 1996, Hardman et al. 1996, Rutledge et al. 1996, Dardik et al. 1998, 
Heller et al. 2000, Hsiang et al. 2001, Noel et al. 2001, Alric et al. 2003, Roddy et al. 2003, 
Visser et al. 2005, Dillavou et al. 2006). The cut-off age for worsening the outcome ranged from 
70 to 80 years (Katz et al. 1994, Hardman et al. 1996, Heller et al. 2000, Roddy et al. 2003). 
Gloviczki et al. (1992) found operative mortality of 56% for patients 80 years or older, compared 
with 47% for those under 80. Barry et al. (1998) found mortalities of 51% and 48%, respectively. 
Hallin et al. (2001) demonstrated relative risk estimates of 1.9–3.1/10 years in their literature 
review of 3 138 RAAA patients (in 1985–1997). The mean operative mortality among patients 
over 80 years was 53% (147/272) with a wide range (37–90%) after repair of RAAA, based on 
14 different reports (Rosset et al. 2006). Opposite results have been reported as well (Harris et al. 
1991, Aune et al. 1995, Halpern et al. 1997, Janczyk et al. 2004). Although high age is a risk 
factor for surgery, survival over 40% is acceptable (Gloviczki et al. 1992). Age is considered to 
be a minor clinical predictor of peri-operative cardiovascular risk by the American College of 
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Cardiology and the American Hearth Association (ACC/AHA) guidelines for peri-operative 





Co-morbidities increase along with ageing, especially vascular diseases. Among 72 over  
80-year-olds (including 63 AAA and 9 RAAA patients) 56% had hypertension, 30% ischemic 
heart disease, 21% peripheral vascular disease, 17% renal failure, and 14% respiratory 
insufficiency (Rosset et al. 2006). Coronary heart disease (Samy et al. 1994, Kniemeyer et al. 
2000), cerebrovascular disease (Samy et al. 1994, Koskas and Kieffer 1997), chronic obstructive 
pulmonary disease (Samy et al. 1994, Dardik et al. 1998), and chronic renal failure (Samy et al. 
1994, Sasaki et al. 1999, Heller et al. 2000) affected mortality after RAAA. Some studies have 
demonstrated no influence of preoperative health status (Seiwert et al. 1995, Halpern et al. 1997, 
Harris et al. 2005). A literature review of preoperative risk factors based on multivariate analyses 
demonstrated that renal failure and COPD were risk factors, but coronary heart disease was not 
(Hallin et al. 2001). Dardik et al. (1998) found that hypertension and pulmonary disease 
correlated with operative mortality. They proposed that diseases might have been overdiagnosed 
by more aggressive coding strategies in many hospitals, as described by Katz et al. (1994). 
Patients who died before reaching the hospital may have had more severe co-morbidities, thus 






There are large databases on the influence of gender after repair of RAAA. Women were less 
likely to undergo surgery (Katz et al. 1997, Evans et al. 2000, Noel et al. 2001, Dueck et al. 
2004a) and had a poorer outcome after repair of RAAA compared with men (Katz et al. 1994, 
Rutledge et al. 1996, Heller et al. 2000, Semmens et al. 2000, Dueck et al. 2004a, Dillavou et al. 
2006). Men were 1.4 times more likely than women to undergo surgery after RAAA, and women 
had a 1.4-fold greater risk for operative death (Katz et al. 1997). However, these results were 
flawed by low operative rates: men 61% and women 49%. The proportion of women was larger 
in the rupture population than in a group of elective repair of AAA patients in a recent study 
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(Dillavou et al. 2006). The reason for these discrepancies is not clear. The advanced age of 
women at the time of rupture has been shown in many studies. Advanced age is associated with 
an increased incidence of co-morbidities such as coronary heart disease and cerebrovascular 
disease. In contrast, gender was not found to be a risk factor for postoperative mortality based on 




Other pre- and intra-operative factors 
 
Free intraperitoneal rupture was associated with higher mortality as compared with 
retroperitoneal rupture (Rantakokko et al. 1983, Turton et al. 2000). In the series of 135 RAAA 
patients, Rantakokko et al. (1983) reported that all 14 out of 65 operated patients with free 
intraperitoneal rupture died. The operative mortality among patients with free intraperitoneal 
rupture was 58%, whereas among patients with massive retroperitoneal haematoma it was 43%, 
and with retroperitoneal staining 24%, respectively (Gloviczki et al. 1992).  
 
Chen et al. (1996) reported three major preoperative predictors for operative mortality, namely, 
unconsciousness OR 3.1 (95% CI 2.2–4.4), advanced age 1.9 (1.5–2.3), and cardiac arrest 1.8 
(1.4–2.4). Co-morbidities were not predictors of operative mortality after RAAA. However, after 
elective repair of AAA, co-morbidities such as previous heart failure OR 2.6 (95% CI 1.7–3.9) 
and peripheral vascular disease 2.9 (2.0–4.3) affected mortality (Chen et al. 1996).  
 
Patients who died in the emergency room (7%) were included in the study of Gloviczki et al. 
(1992) who reported systolic blood pressure <90 mmHg to predict hospital mortality by OR 3.0 
(95% CI 1.5–6.1) and haematocrit 1.3 (1.1–1.7). Preoperative haematocrit <28 predicted 72% 
mortality among RAAA patients (Gloviczki et al. 1992). Haemoglobin below 90 g/l predicted 
operative mortality (Hardman et al. 1996, Kniemeyer et al. 2000) as did acute renal failure 
measured by serum creatine level >190 µmol/l (Hardman et al. 1996). 
 
Samy et al. (1994) demonstrated that shock was a pre-eminent prognostic factor in assessing 
outcome after repair of RAAA. The diagnosis of shock was based on retrospective clinical 
information of hypotension, tachycardia, pallor, and sweating. It could be assumed that the latter 
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two were not so easily retrievable from the medical files. Without a strict definition of shock the 
results may be biased.  
 
A predictor of mortality after repair of RAAA was ischemia confirmed by electrocardiograph 
(ECG) by OR of 6.6 (95% CI 1.8–24.3) (Hardman et al. 1996). Ischemia was defined as greater 
than a 1 mm ST segment depression or an associated T-wave change present on the admission 
ECG. In a recent study by Tambyraja et al. (2005a), an increase in cardiac troponin I (cTnI) 
predicted operative mortality after RAAA. 23 of the 50 patients had an elevated cTnI level, and 
11 of these had ischemia confirmed by ECG. Also the serum creatine level was higher in the 
patients with an elevated cTnI level. Elevated cTnI levels, however, were associated with other 
diseases, such as renal failure (Ammann et al. 2004).  
 
Intraoperative temperatures of 36, 34, and 32 oC predicted operative mortality: 15%, 49%, and 
84%, respectively (Janczyk et al. 2004). Base deficit was also an intraoperative predictor, 
survivors having a mean of –5.1 (±5.4) base deficit and non-survivors –12.9 (±7.2) (Janczyk et 













































































































































































































































































































































































































































































































































































































































































































































































































After postoperative treatment of at least 24–48 hours in the ICU, the predictors of mortality 
differed from the predictors for preoperative or overall mortality (Maziak et al. 1998, Kniemeyer 
et al. 2000, Bown et al. 2004). In a series of 222 RAAA patients, 18% were considered unfit for 
surgery (Bown et al. 2004). Of the 181 operated patients, 141 survived at least 24 h after initial 
surgery. Mortality after 24 h was 32%, and multiple organ dysfunction was responsible for 60% 
of the deaths. Kniemeyer et al. (2000) reported that multiple organ dysfunction was the cause of 
death in 93% of the postoperatively deceased patients. The cause of death was haemorrhagic 
shock for the patients who died intraoperatively (Kniemeyer et al. 2000, Bown et al. 2004). 
 
Chen et al. (1996) reported predictors of postoperative mortality for patients who survived after 
the initial surgery. These were: coagulopathy, (defined as a prothrombin time >4 seconds versus 
control or thrombocytopenia <60 x 109/l) OR 7.9 (95% CI 4.1–15.5), ischemic colitis 6.4  
(3.4–12.2), adrenergic agents used >48 hours 4.8 (3.0–7.6), admission to operating room >1 hour 
4.6 (2.6–8.3), perioperative myocardial infarction 4.0 (2.1–7.7), and renal failure (serum 
creatinine level >230 µmol/l) 3.7 (1.9–7.5). Advanced age was also a predictor by OR 4.0  
(2.1–8.0) per 10 years.  
 
Acute renal failure after RAAA is a severe complication. Bown et al. (2004) described renal 
complications in 32% of the patients who survived at least 24 h after initial surgery; half of them 
required renal replacement therapy. Renal complications were associated with mortality as high 
as 70%, OR 9.5 (3.1–28.6). Barratt et al. (2000) analysed the outcome of acute renal failure after 
repair of RAAA in a series of 65 patients. Acute renal failure was defined by serum creatinine 
level >600 µmol/l, or necessary renal replacement therapy. Acute renal failure occurred at  
a median of 4 days (range 1–14 days) after surgery. The presence of a vascular disease, 
additional surgery required, and multiple organ dysfunction were predictors of mortality. Of the 
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Measures predicting mortality  
 
Few scoring methods have been tested in a retrospective fashion in patients with RAAA. In order 
for scoring methods to be useful, they should be readily available already in the emergency room 
to facilitate initial patient selection. In an emergency situation, only few data are available. In the 
case of an unconscious patient, the patient’s history may remain totally unknown and his/her co-
morbidities unidentified, as laboratory test results might not be available at the time of deciding 
to operate or not. Variables of different scoring methods are presented in Table 7.        
 
 
Glasgow Aneurysm Score 
 
The preoperative Glasgow Aneurysm Score (GAS) was established to provide a scoring system 
for predicting the outcome after elective or emergency repair of AAA (Samy et al. 1994). The 
same authors validated the scoring system prospectively using a different study population 
(Samy et al. 1996). This simple preoperative score is calculated using the following formula: risk 
score = (age in years) + (17 points for shock) + (7 points for myocardial disease) + (10 points for 
cerebrovascular disease) + (14 points for renal disease). A diagnosis of shock is based on clinical 
information on hypotension, tachycardia, pallor, and sweating. Myocardial disease refers to  
a previously documented myocardial infarction and ongoing angina pectoris, or both. 
Cerebrovascular disease refers to all grades of stroke and included transient ischemic attack. 
Renal disease refers to a history of chronic and acute renal failure, and/or serum urea level >20 
µmol/l and/or serum creatinine level >150 µmol/l at the presentation. GAS >95 predicted death 
in 80% of the cases in the series of 92 RAAA patients (Samy et al. 1996). 
 
The preoperative GAS predicted mortality after elective AAA surgery (Biancari et al. 2003a, Leo 
et al. 2005, Nesi et al. 2004). The best cut-off level to predict poor outcome was GAS >78 in the 
study by Biancari et al. (2003a) and >76 in the Finnvasc study (Biancari et al. 2003b). The Area 
under the Receiver operator characteristic (ROC) curve was 0.80 (95% CI 0.71–0.90), operative 
mortality was 1.4% with a score of <78, and 8.7% with a score of >78 (Biancari et al. 2003b). As 
regards RAAA, Tambyraja et al. (2005c) showed in a series of 82 RAAA patients that GAS was 
a poor predictor of outcome, AUC 0.61 (95% CI 0.48–0.73). The median GAS for survivors was 
93 and for non-survivors 96. The median GAS of the 18 patients unfit for surgery and excluded 
from the analysis was 102.  
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Hardman Index 
 
Hardman et al. (1996) identified five risk factors that were easily determined on presentation to 
the emergency room. The risk factors had cumulative predictive value when three or more of the 
five factors were associated with 100% mortality. These risk factors were: age >76 years, loss of 
consciousness after arrival, ischemia confirmed by ECG, haemoglobin <90 g/l, and serum 
creatinine level >190 µmol/l. In the first studies, a score of three or more risk factors predicted 
fatal outcome, although the number of patients at risk was small (n=20) (Boyle et al. 2003, 
Prance et al. 1999). In later studies there were 7/19 hospital survivors with three or more risk 
factors after RAAA (Neary et al. 2003, Calderwood et al. 2004, Tambyraja et al. 2005c). 
Furthermore, one of these succumbed at a nursing home six weeks after hospital discharge 
(Neary et al. 2003) and two were in the communal rehabilitation hospital (Tambyraja et al. 





Copeland et al. (1991) derived a scoring method called The Physiological and Operative Severity 
Score for the enUmeration of Mortality and morbidity (POSSUM) for surgical patients. It was 
later developed and modified with regression equations for vascular patients (V-POSSUM) 
(Prytherch et al. 1998) and for RAAA patients (RAAA-POSSUM) (Prytherch et al. 2001). The 
POSSUM consists of two components: 12 physiology and 6 operative variables. The RAAA-
POSSUM has two variants: one uses both a physiological and operative score; the other  
a preoperative physiological score only. Of the POSSUM scores, only the RAAA-POSSUM 
physiology score can be calculated before the operation. The RAAA-POSSUM as well as 
Portsmouth-POSSUM (P-POSSUM), and V-POSSUM predicted mortality after repair of RAAA, 
as did the Hardman Index in a recent study, but the Hardman Index was easier to calculate 
(Neary et al. 2003). Lazarides et al. (1997) used the conventional POSSUM score and failed in 
predicting the outcome after RAAA, as did Bown et al. (2004), in all POSSUM models except 
the V-POSSUM and P-POSSUM. 
 
Models based on the POSSUM data set have been observed to be vulnerable to incomplete data, 
as a large amount of information is required on every patient. Furthermore, some components of 
the data set are subjective rather than objective (Prytherch et al. 2005).               
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VBHOM 
 
The Vascular Biochemistry and Haematology Outcome Models (VBHOM) were designed to 
minimize data gathering and quality problems (Prytherch et al. 2003). The VBHOM uses seven 
items which can be constructed from hospital pathology and patient administration computer 
systems. It failed to model the outcome as a combined group for RAAA and elective repair of 
AAA, and necessitated the formation of two separate models for elective and emergency surgery 
(Prytherch et al. 2005).  
 
 
APACHE II  
 
The Acute Physiologic and Chronic Health Evaluation (APACHE II) scoring system is validated 
and used widely in critical care to assess the severity of diseases (Knaus et al. 1985). It is based 
on 12 physiologic and laboratory factors, as well as on age and chronic health status. Many 
studies have indicated that the APACHE II score is a good predictor of outcome after RAAA 
(Gloviczki et al. 1992, Maziak et al. 1998, Ho et al. 1999). Gloviczki et al. (1992) found the 
mean APACHE score at admission to be 11.3 for survivors and 19.1 for non-survivors, OR 1.50 
(95% CI 1.2-1.9). Patients unfit for surgery were included. Also Lazarides et al. (1997) found  
a high score to be associated with death, but its power to predict outcome was limited in 
individual patients. They reported a mean APACHE II score of 11.3 for survivors and 14.5 for 
non-survivors (Lazarides et al. 1997), although APACHE II was never intended to predict death 
at the individual level (Chang 1989).  
 
The APACHE II has been modified and internally validated for AAA patients (APACHE II-
AAA) to predict mortality after elective and emergency surgery (Hadjianastassiou et al. 2005). 
The following components from APACHE II were chosen: Acute Physiology Score, chronic 
health status classified as binary, operative urgency, and chronological age. The APACHE-AAA 
model had better calibration than the original APACHE II model in predicting outcome after 
repair of AAA. Of the 1896 cases, 605 were emergency ones. Also in different age groups the 
APACHE-AAA predicted operative mortality better than the APACHE II. The hierarchical 
methodology used to develop the APACHE-AAA model makes it flexible to adjust for the 
hospital-related factors, which also affect outcome in addition to the patient-casemix.  
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Hadjianastassiou et al. (2006) compared different prediction models in the ICU after repair of 
RAAA. Statistical modelling by multiple regression analysis was the best model of assessing 
hospital mortality when compared to the clinician’s estimate or artificial neural network, which 
is a computational, mathematic tool for information processing. The covariates included in the 
multiple regression analysis were age, Acute Physiology Score, chronic health status, and 





Various organ dysfunction scores have been described for general use in the ICU. The Sequential 
Organ Failure Assessment (SOFA) is a scoring instrument used to quantify the severity of organ 
dysfunction in critically ill patients (Vincent et al. 1998). The SOFA score (score 0–4) is defined 
as follows: Pa02/Fi02 for respiratory failure, creatinine level, urine output, or renal 
hemofiltration or hemodialysis for renal, bilirubin for liver, mean arterial pressure, 
dopamine/doputamine or epinephrine/ norepinephrine administered for the cardiovascular 
system, platelet count for coagulation, and Glasgow Coma Scale for central nervous system 
(Vincent et al. 1998). There were no studies available in which SOFA score was used for RAAA 
patients. 
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SOFA = Sequential Organ Failure Assessment; VBHOM = Vascular Biochemistry and Haematology Outcome 
Models; POSSUM = The Physiological and Operative Severity Score for the enUmeration of Mortality and 
morbidity; APACHE II = Acute Physiologic and Chronic Health Evaluation; Preoper. = preoperative score;  
Postoper. = postoperative score; ECG = Electrocardiograph   
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AIMS OF THE PRESENT STUDY 
 
 
The main purpose of this study was to evaluate the outcome and factors predicting mortality in 
ruptured abdominal aortic aneurysm (RAAA) in Helsinki and Uusimaa district.  
 
The specific aims were to assess: 
1. The 30-day operative, hospital, and population-based mortality, and  
effects of organisational changes on outcome after RAAA. (I–V) 
2. Quality of life of patients undergoing repair of RAAA. (I, II) 
3. The number of quality-adjusted life years (QALY) following RAAA  
and factors related to QALYs. (II) 
4. Predictors of outcome after RAAA. (II–IV) 
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PATIENTS AND METHODS 
  
 
Data source  
 
Data from Helsinki University Central Hospital (HUCH) was retrieved from the patient records, 
Hospital Discharge Registry, and the Cause of Death Registry of Statistics Finland. The outcome 
status of all patients was cross-referenced by a manual case record review, and computerised 
patient administration system of HUCH was used, if needed. All Helsinki and Uusimaa data 
were retrieved from the Cause of Death Registry of Statistics Finland. The death certificates of 
all patients were recorded. National Finnvasc registry data were collected from the beginning of 
1991 to 1999. Details of the Finnvasc registry have been described previously (Salenius 1992).  
 
The protocols of the quality of life (QoL) studies (I, II) were approved by the Ethics Committee 
of the HUCH. All retrospective studies had a licence for document research approved by the 
Surgical Board of HUCH. 
 
 
PATIENTS AND STUDY DESIGNS 
 
Altogether 1381 RAAA patients were included in five studies (I–V) in 1991–2004 (Figure 1). Of 
the 1381 RAAA patients, 1087 underwent repair for RAAA. 13 patients were excluded from the 
analysis of operative treatment due to their operation outside HUCH, and they were not included 
in the Finnvasc data either. The mean age of the 1074 operated RAAA patients was 71 years 
(median 71, range 43–94 years) and 86% were men (Table 8). 13% (139/1074) were over 80 
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*81 RAAA patients were included in both the Helsinki and Uusimaa (V) and the Finnvasc (III) study population  
 
Figure 1. A total of 1381 RAAA patients in the different study years (1996–2004) and the number of patients (I–V). 
 
 
Table 8. Demographic data on 1074 RAAA patients who underwent repair of RAAA in 1991-2004. 
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Study I  
 
The study included 220 RAAA patients in HUCH in 1996–2000 (Table 9). The long-term 
survival and QoL of 220 RAAA patients were studied. The validated Finnish version of the 
RAND 36-item Health Survey 1.0 (RAND-36) questionnaire, along with a cover letter 
explaining the study, were mailed to 93 long-term surviving RAAA patients (Aalto et al. 1999). 




The study comprised 269 RAAA patients admitted in HUCH for RAAA in 1996–2002 (Table 9). 
QALYs were calculated for all RAAA patients and for survivors. The date of death of each 
patient based on the social security number was checked from Statistics Finland, and the life 
expectancies of the surviving patients were then calculated using the life expectancy of the age- 
and sex-adjusted population obtained from Statistics Finland. The EQ-5D questionnaire was 
used for QoL evaluation. Of the surviving 129 patients (129/269), 111 patients were available for 
QoL assessment. Factors affecting the number of QALYs and hospital survival were evaluated. 
Preoperative scores of APACHE II, SOFA, Glasgow Aneurysm Score (GAS), and Hardman 
index were calculated retrospectively from the medical files. The Hardman index was calculated 
and handled as a dichotomous variable: if 3 or more preoperative factors were positive, the score 
was considered positive. 
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QoL = Quality of life 
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Study III 
 
From January 1991 to December 1999, 836 patients underwent open repair of RAAA in 
Finland according to the Finnvasc registry. Pre-, intra-, and postoperative data were collected 
from the national Finnvasc registry on 836 RAAA patients. Details of the Finnvasc registry 
have been described previously (Salenius 1992). The influence of the GAS and that of 
analysed risk factors on 30-day operative mortality were evaluated. We also included  
a number of other risk factors and used the Finnvasc definition criteria for coronary artery 
disease, cerebrovascular disease, diabetes, hyperlipidemia, hypertension, pulmonary disease, 





This retrospective study comprised 197 RAAA patients in 1999–2003 in HUCH. The aim was 
to identify predictive factors for 30-day operative mortality after 48 h of maximal treatment in 
the ICU after repair of RAAA. Of these 197 RAAA patients, 185 underwent surgery and 138 
survived at least 48 h. The survivors were included in a study, and 122 factors were reviewed 
from the medical files. The effect of multiple organ dysfunction, defined according to the 





The study included all RAAA patients identified in Helsinki and Uusimaa district in 1996–2004. 
A total of 626 patients had RAAA, 352 (56%) were admitted to HUCH. Regional centralisation 
and quality improvements in the treatment chain of RAAA were performed in the years 1999 to 
2002 in HUCH. During the regional reorganisation, the vascular service was centralised at the 
Department of Vascular Surgery of HUCH in the Meilahti Hospital from 1999 onwards in the 
hospital district of Helsinki and Uusimaa. In-hospital reorganisation included a new surgical 
intensive care unit (ICU), established in 2001. The on-call system has also been reformed over 
the years from a single vascular surgical consultant at home to a vascular trainee in the hospital 
and a senior vascular surgeon on call at home, as of 2003. The study period was divided into 
three phases: I control period (1996–1998), II change period (1999–2002), and III present 
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organisational period (2003–2004). The impact of organisational changes on mortality was 
assessed by comparing the time periods. Data were collected retrospectively from the medical 
files and death certificates. Patients having undergone open surgery and treated with 
endovascular repair were included (Table 10). The profile of patients according to their age, 
gender, and GAS was recorded. 
 
































Male (%) 24 (73) 
 




















Quality of life (I, II) 
 
RAND 36 (I) 
 
The validated Finnish version (Aalto et al. 1999) of the RAND 36-item Health Survey 1.0 (Hays 
et al. 1993) questionnaire was mailed for self-administration to the patients known to be alive 
after repair of RAAA. Any help required in the administration was recorded. In cases of no 
initial response, the questionnaire was resent. If there was no response after two mailings,  
the patients were contacted by phone. The details of the RAND-36 measure are given on the 
page 27.  
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EQ-5D (II) 
 
The validated EQ-5D questionnaire (The EuroQol Group 1990) was chosen because the results 
could be used as a single index for calculating QALYs. The questionnaire was sent for self-
administration to the patients known to be alive after repair of RAAA. Any help required in 
administration was recorded. In cases of no initial response, the questionnaire was resent. 
 
The details of the EQ-5D measure are given on the page 27. The results were expressed as the 
EQ-5D index and EQ-VAS. The EQ-5D index and the EQ-VAS values of the study population 
were compared with the age- and sex-adjusted general Finnish population values; that for the 
EQ-5D index was 0.795 (median 0.785, range 0.600 to 1.000) and that for the EQ-VAS was 68 
(median 68, range 56–77) (Ohinmaa and Sintonen 1999). 
 
 
Quality-adjusted life years (II) 
 
The assessment of quality-adjusted life years (QALY) aims at combining the length and quality 
of life. The quality adjustment ranges from 0 (death) to 1 (perfect health). The EQ-5D index was 
used to assess the QoL of the RAAA patients. A patients with hospital mortality had a value of  
0 QALY. If the endpoint was not reached during the follow-up period, then estimates of life 
expectancies derived from the age- and sex-adjusted population were used. For the non-
respondents also pessimistic QALYs were calculated as 75% of the QoL indices and 75% life 
expectancy according to the age- and sex-adjusted population for survivors. 
 
 
Glasgow Aneurysm Score (II–V) 
 
The preoperative Glasgow Aneurysm Score (GAS) for each RAAA patient was calculated 
according to the score formula (II–V). Details of the score are given on the page 35. The value of 
the GAS as a preoperative predictor of hospital mortality was evaluated (II–IV) as well as GAS 
affecting the number of QALYs (II). The GAS was used to assess the preoperative profile of the 
hospitalised RAAA patient (V).       
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SOFA (II, IV) 
 
Organ dysfunction was defined as a SOFA score; the SOFA is described on page 38. The SOFA 
was used for preoperative assessment (II). In Study IV the SOFA scores were calculated 
postoperatively on day 1, 2 (48-h), 3, 7, 14, and 21 until the patients were discharged. If  
a laboratory value was missing, the previous day’s value was used, and if the previous day’s 
value was missing, the next day’s value was used. If both of these values were missing, the 
values from two earlier days or the following two days were used. If all these values were 
missing, the value was considered as unavailable and was calculated as a normal value. The 
Glasgow Coma Scale was considered to be normal in sedated patients if there was no known 





The death certificates of all RAAA patients deceased during 1996–2004 in the Helsinki and 
Uusimaa district were reviewed from the Cause of Death Registry, Statistics Finland. Mortality 
was presented as 30-day operative mortality (only operated RAAA patients) and hospital 
mortality, which included all RAAA deaths during the same hospitalisation. Hospital mortality 
included also moribund RAAA patients who were unfit for surgery, and patients having RAAA 
as the cause of death at autopsy. Population-based mortality was calculated including all 





Statistical analysis was performed with the SPSS statistical program, SPSS version 10.5, 
Chicago, IL, USA (I–III); SPSS version 11.0, Chicago, IL, USA (IV); SPSS version 12.0, 
Chicago, IL, USA (V). 
 
The non-parametric Mann-Whitney U-test (for continuous variables) and the Chi-square test 
were used for comparisons between survivors and non-survivors (II–IV), and the study 
population versus norms for an age- and sex-adjusted normal population (I). The results were 
expressed as Z scores, i.e. the difference between the mean and the adjusted population mean 
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divided by the adjusted population standard deviation (I). The nonparametric Spearman’s 
correlation test was performed to detect significant correlations between QALYs, and pre-, peri- 
and postoperative factors (II). Chi-square test was used to compare the number of deaths 
between the three study phases (V). Differences in continuous variables between the three phases 
were tested by the nonparametric Kruskal-Wallis test (V). 
 
The receiver operating characteristic (ROC) curve (Harrell et al. 1996) was used to evaluate the 
value of the GAS in predicting postoperative death (III) and independent predictive factors for 
mortality (IV). AUC values (Area under the curve) between 0.7 and 0.8 represented reasonable 
discrimination, whereas values >0.8 could be considered good. 
 
Logistic regression with backward stepwise selection was used for the multivariate analysis of 
the variables affecting the outcome (III). The significant effects of the factors on QALYs were 
assessed using forward stepwise linear regression analysis (II). Forward stepwise logistic 
regression analysis was performed to evaluate factors affecting 30-day operative (IV) and 
hospital mortality (II). Only those variables with a p<0.05 at univariate analysis were included in 
the regression models (III, IV). The correct classification rate (CCR) was determined for the best 
model (IV). An accessory Bayes model (B-Course 2.0, Helsinki Institute of Information 
Technology, Helsinki, Finland) was created to evaluate the factors affecting QALYs (II).  
 
A p<0.05 was considered statistically significant. In Study II, however, p<0.01 was considered 
statistically significant due to multiple comparisons. 
 






A total of 626 patients with RAAA were identified in the Helsinki and Uusimaa district in 1996–
2004 (Figure 2). 352 (56%) of the 626 patients, were admitted to HUCH. Hospital was the place 
of death for 61% of all RAAA mortalities (Table 11). 
 
 
  RAAA  





Deaths outside HUCH       HUCH  
274 (44%)    352 (56%) 





Operative treatment  Endovascular treatment Non-operative treatment 
315 (90%)  4 (1%)  33 (9%)  
    -unfit for surgery 23 
    -diagnosed at autopsy 10 
 
 
Survivors         Deaths  Survivors Deaths Deaths 
196 (62%)        119 (38%)  2 (50%) 2 (50%) 33 (100%) 
     
       








30-day operative  
mortality 38%  
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Table 11. Place of death of patients with RAAA in the Helsinki and Uusimaa district in 1996–2004. 
 
Place of death N % 
HUCH 157 36 
Other Hospitals 106 25 
Home 135 31 
Elsewhere 33 8 




In HUCH 33 patients did not undergo surgery; 21 of them were assessed as moribund or unfit for 
surgery, and 12 were missing primary identification and diagnosed RAAA at autopsy without 
any vascular consultation. The reasons for non-operative management of diagnosed RAAA were 
cardiac arrest or loss of consciousness (33%), age-related co-morbidities (18%), malignancy 
(6%), and patient refusal (6%) (Table 12). 
 
 
Table 12. Reasons for non-operative management in 33 RAAA patients in Helsinki University Central Hospital. 
 
Reason N % 
Cardiac arrest/ Loss of consciousness 11 33 
Age-related co-morbidity 6 18 
Malignancy 2 6 
Patient refusal 2 6 
RAAA diagnosed at autopsy 12 36 




The profile of patients according to age, gender, and GAS did not change over the years 1996–
2004, nor did time from admission to beginning of the operation. The 30-day operative mortality 
was 38%, hospital mortality 45%, and population-based mortality 69% (V) (Table 13). Mortality 
decreased significantly during the third time period  (2003–2004); 30-day mortality was 19%, 
hospital mortality 28%, and population-based mortality 56% (Figure 3). 
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Table 13. Proportions of 30-day operative, hospital, and population-based mortality of RAAA patients (I-V). 
 
Study 30-day operative mortality (%) Hospital mortality (%) Population-based mortality (%) 
I 82/199 (41) NA NA 
II 106/242 (44) 140/269 (52) NA 
III 395/836 (47) NA NA 
IV 78/185 (42) 93/197 (47) NA 
V 115/315 (38) 157/352 (45) 431/626 (69) 
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Of 352 RAAA patients in HUCH, 67 (19%) were over 80 years of age and 15 of them were not 
operated. Of the 52 aged patients who underwent surgery, 56% (29/52) died. Hospital mortality 
was thus 66% (44/67) for patients older than 80 years.  
 
The mean frequency of RAAA during the study was 5.4 RAAAs/100 000 population per year 
(range 4.5-6.5/100 000) (Table 14). 
 
 
Table 14. The frequency of RAAA in the Helsinki and Uusimaa hospital district in 1996–2004 retrieved from the 
Hospital Discharge Registry and the Cause of Death Registry, Statistics Finland.  
 
Year Population1  
N 
All RAAA  
N 
RAAAs/ 




1996 1 240 301 63 5.1 3.9 
1997 1 257 702 70 5.6 4.3 
1998 1 274 475 83 6.5 5.2 
1999 1 290 618 60 4.7 2.9 
2000 1 304 595 76 5.8 3.6 
2001 1 318 324 68 5.2 3.8 
2002 1 329 004 78 5.9 4.4 
2003 1 338 180 60 4.5 2.3 
2004 1 346 958 68 5.1 2.9 
 
1 Population according to Statistics Finland. 
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QUALITY OF LIFE 
 
The response rate to the RAND-36 questionnaire was 88% (82/93). Non-responders were 
contacted by phone: 2 out of 11 were still working, 6 lived at home without outside help, and  
3 could not be contacted. The questionnaire was self-administered by 71% and with assistance 
by proxy in the case of 29%.  Eight domains of QoL were compared with norms for the age- and 
sex-adjusted general population, and only physical functioning was significantly impaired 
(p=0.01) (Figure 4). When expressed as a Z score, the difference was –1.21. (I) 
 
The EQ-5D questionnaire response rate was 85% (94/111). The questionnaires were self-
administered by 71% and with assistance by 29%. The mean EQ-5D index for respondents was 
0.685 (median 0.676, range 0.072–1.000) and significantly lower as compared to the age- and 
sex-adjusted Finnish general population 0.795 (median 0.785, range 0.600–1.000) (p=0.001). 
The mean EQ-VAS was 61 (median 63, range 10–100) and did not differ from that of the age- 
and sex-adjusted Finnish general population, 68 (median 68, range 56–77) (p=0.76). (II) 
 
 
QUALITY-ADJUSTED LIFE YEARS 
 
The mean (range) number of QALYs after RAAA was 4.1 (0–30.9) for all RAAA patients and 
8.5 (0.2–30.9) for hospital survivors. The mean numbers of QALYs according to a pessimistic 
assessment were 2.2 for all RAAA patients and 4.5 for hospital survivors. Young age and low 
GAS were associated with a high number of QALYs. There were 2 survivors among the  
21 patients with a Hardman score of three or more; they gained 7.3 and 6.5 QALYs, 
respectively.  
 
Of the 129 survivors, 120 gained at least one QALY, of whom 120 patients 16 were >80 years 
old (34 non-survivors aged >80 years old). Of the patients >80 years old and with GAS >100,  
5 patients gained at least one QALY  (23 non-survivors aged >80 and GAS >100).  
 
The BAYES model, using all data independently and quartiles of QALYs as the dependent 
variable, revealed that GAS was the only factor independently associated with the number of 
QALYs. 
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Figure 4. The patients’ quality of life after RAAA according to the eight health domains of the RAND-36, 
compared with the norms of the Finnish age- and sex-adjusted population. The results as median, inter-
quartile range and range. Reproduced from Korhonen et al. 2003, with permission. 
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PREDICTORS OF OUTCOME  
 
Glasgow Aneurysm Score 
 
The mean GAS among RAAA patients who died (395/836) was 91.1 (standard deviation 11.5), 
whereas it was 79.6 (12.8) among the survivors (441/836) (p<0.001). Quintiles of the GAS 
predicted 30-day operative mortality (p<0.001) (Figure 5). Predictors of mortality in multivariate 
analysis were preoperative shock OR 2.13 (95% CI 1.45–3.11) and an increase of 10 units in the 
GAS OR 1.81 (95% CI 1.54–2.12). The ROC curve showed that the best cut-off point of the 
GAS in predicting 30-day operative death was 84 (AUC 0.75, 95% CI 0.72–0.78, Standard Error 
0.17) (Figure 6). Patients with a GAS ≤ 84 had a 30-day mortality rate of 28.2% (114/404), 
whereas it was 65.0% (281/432) among those with a score >84 (III). During the years 2003–2004 
with an optimised treatment chain of RAAA, if cut-off points of GAS >105 and age >80 were 
used, 4 survivors out of 12 RAAA patients would have been missed (V). When all RAAA 
patients in the period of 1996 to 2004 were included and tested with different GAS cut-off points 
(95–115) and age >80, the mortality rate ranged from 75–82% (Figure 7). With a GAS >120 and 
age >80 all five patients died. 
 
In order to test the potential confounding effect of factors related to different hospital practices, 
the nationwide data were divided according to the hospital volume. Six hospitals with more than 
50 cases of repair of RAAA were analysed separately, whereas other hospitals with less than  
50 repair cases of RAAA were clustered together as one. In 6 of the 7 hospitals tested, GAS 
predicted outcome (P<0.05): the lower the GAS, the better the outcome. 
 
Preoperative GAS was an independent predictor of death after 48-h survival after RAAA repair 
(AUC 0.67 (95% CI 0.56–0.78)) together with organ dysfunction by SOFA score at 48-h, and 





The preoperatively measured APACHE II scores differed significantly between survivors and 
non-survivors after RAAA. All RAAA patients had an APACHE II score median of 14 (range  
3–37), the survivors 12 (3–30), and non-survivors 16.5 (5–37), respectively (p<0.001). (II)  
 
















< 73 74-82 83-89 90-97 > 98

























Figure 5. The 30-day mortality rates in different quintiles of the Glasgow Aneurysm Score in patients who 

















Figure 6. Receiver operating characteristics (ROC) curve for the Glasgow Aneurysm Score in predicting 
postoperative mortality (Area Under the Curve 0.75, 95% CI 0.72–0.78, SE 0.017, p<0.001). 
 
 
 57  




























>80 >95 13 39 75 
>80 >100 10 31 76  
>80 >105 7 21 75 
>80 >110 3 14 82 
>80 >115 2 9 82  
>80 >120 0 5 100  
 
 
Figure 7. Glasgow Aneurysm Score (GAS) and age related to hospital mortality after RAAA with different 
cut-off points of the GAS and age.    
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 Predictors at 48 hours 
 
The 30-day operative mortality of 197 RAAA patients was 42% (78/185) and hospital 
mortality 47% (93/197) (Figure 8). Of the 12 patients not operated, five were considered 
moribund, and seven RAAA deaths were diagnosed at autopsy. 10% (19/185) died 
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Surgery                        Non-operated 
 185  12 (6%) 





Survivors >48-h Intraoperative deaths 19 (10%) 





Survivors Deaths >48-h 31 
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When the characteristics and preoperative values of the RAAA patients were compared, age, 
preoperative GAS, and shock differed significantly between the survivors and non-survivors. 
Suprarenal clamping was used more often for non-survivors (42% versus 19%, p=0.009).   
 
In the multiple logistic regression analysis, the SOFA score at day 2 (48-h) (p<0.001), 
preoperative Glasgow Aneurysm Score (p=0.03), and suprarenal clamping (p=0.04) were 
independent predictors of 30-day operative mortality 48 h after repair of RAAA. The Areas 
under the ROC curves (AUC) of significant measures of multivariate analysis were 0.79 (95% CI 
0.70–0.89) for day 2 SOFA score, and 0.67 (95% CI 0.56–0.78) for preoperative Glasgow 
Aneurysm Score, respectively. At day 2 (48-h), a cut-off point for the SOFA score >11 predicted 
mortality with a sensitivity of 39% and a specificity of 93%, and at day 7 63% and 98%, 
respectively. 
  
The mean daily measured SOFA scores for survivors and non-survivors differed from day 1 
onwards, displaying the greatest difference at day 7 (Figure 9). Out of 138 SOFA scores, 118 
overlapped at day 2 (48-h) after repair of RAAA (Figure 10). Development of cardiovascular 
and/or renal failure differed significantly between the survivors and non-survivors as measured 
by daily SOFA scores (Figure 11).  
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Figure 9. Development of mean (CI 95%) daily SOFA scores in 138 patients after repair of RAAA.  






















Figure 10. SOFA Score at 48 h (day 2) after repair of RAAA. The results are shown as median,  
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Figure 11. Development of single organ dysfunction as measured by mean (95% CI) SOFA scores in survivors and 
non-survivors after surgery for RAAA. The significant differences are framed. Reproduced from Laukontaus et al. 
2005, with permission.
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COST-EFFECTIVENESS ANALYSIS  
 
The costs were analysed further, as measuring the QALYs enables the calculation of cost-
effectiveness ratios. The costs were assessed using the following pricelist of HUCH, 2006: 
RAAA operation 4000 €, one day at the ICU 2 500 €, one day at the ward 350 €, and deaths in 
the emergency room 400 €. The costs of RAAA were 15 650 € per patient, 19 400 € per 
survivor, and 11 000 € per non-survivor (Table 15). With the hospital mortality rate of 45% 
(157/352) the mean cost for a survivor of RAAA was 28 300 €. The cost-effectiveness ratio was 
thus 6 900 €/QALY  (28 300 €/4.1 QALY). To assess the reliability of these cost estimates, 
further calculation of the actual costs was done for 70 consecutive RAAA patients, resulting in  
a mean cost of 17 700 € (range 140–76 500 €). 
 
In the subgroup of age >80 years and GAS >100, the cost of RAAA was 9 500 € per patient,  
16 000 € per survivor, and 7 300 € per non-survivor (Table 15). With the hospital mortality rate 
of 76% (31/41) the mean cost for a survivor of RAAA was 38 800 €. The cost-effectiveness ratio 
was thus 35 300 €/QALY (38 800 €/1.1 QALY).  
 
One RAAA patient used a mean of 3.9 ICU days and 6.5 ward days (Table 15). A survivor used 
a mean of 4.8 ICU days and a mean of 10.4 ward days, and a non-survivor 3.1 and 2.2 days, 
respectively. When the ICU and ward days of all patients were divided among the survivors, the 
mean figures were 7.4 and 13.5 days, respectively. When the ICU and ward days of all patients 
in the subgroup of age >80 years and GAS >100 were divided among the survivors, the mean 
figures were 7.4 and 14.5 days, respectively.  
 
For 28 patients aged >80 years and Glasgow Aneurysm Score >100, the mean QALY was 1.1 
(0–7.9). Five of the RAAA patients survived and gained together 29.5 QALYs, which comes to 
about 8 500 €/QALY in the cost-effectiveness analysis (Table 16). (II)  
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Table 15. Costs and length of stay in the intensive care unit (ICU) and in the ward for all survivors and non-
survivors, for the group age >80 years and for the subgroup of age >80 years, and the Glasgow Aneurysm Score 
>100 after RAAA, in 1996–2004. 
 
 Survivor   Non- survivor  
 All Age >80 Age>80, 
GAS >100 




195 23 10 157 44 31 



































































































   
 




Table 16. The total number of QALYs and the cost-effectiveness ratio for RAAA patients aged >80 years and with 
different Glasgow Aneurysm Scores. 
 
Age, years GAS Survivors n 
 
Non-survivors n Total QALYs Cost-effectiveness ratio 
(€/QALY) 
>80 >95 8 29 34.75 8 900 
>80 >100 5 23 29.51 8 500 
>80 >105 4 14 22.46 4 800 
>80 >110 2 10 9.25 11 400 
>80 >115 2 6 9.25  8 200 
>80 >120 0 2 0  
 
GAS = Glasgow Aneurysm Score; QALY = Quality-adjusted life year  
 




From rupture to emergency room 
 
In the Helsinki and Uusimaa district, some 70 persons had RAAA annually during the study 
years 1996–2004. Almost one third of the deaths resulting from RAAA occurred at home and 
were diagnosed at autopsy. One fifth of the RAAA deaths occurred in other hospitals, outside 
HUCH. Only a small minority of the patients admitted to other hospitals were operated on. These 
results were parallel to those reported recently by Heikkinen et al. (2002) in the Pirkanmaa 
district.    
 
More than half of all RAAA patients were admitted to the emergency unit of HUCH, which has 
had ‘all comers policy’, and principally all were candidates for surgery. In the present study 6% 
of the patients diagnosed to have RAAA were not operated. The operative rate was one of the 
highest in the published literature, and in line only with the series of Barry et al. (1998) and Noel 
et al. (2001). Attempts have been made to identify predictors of mortality, but no single 
preoperative parameter to indicate definite outcome is available (Halpern et al. 1997, Sasaki et 
al. 1999 Heller et al. 2000, Calderwood et al. 2004, Janczyk et al. 2004). Knowledge of a single 
risk factor adds little to the decision-making process in the emergency room, whereas knowledge 
of the global operative risk may ideally help the surgeon to decide whether to operate or not if 
the patient has a high operative risk. 
 
A selection criterion is to identify patients who are not cases for salvage attempts. To discover 
individual operative risk by using the risk stratification scoring system is practical in the 
emergency setting, but only if it can be done reliably. The preoperative Glasgow Aneurysm 
Score (GAS) is a simple prediction tool with only five easily available preoperative variables. In 
fact, the patient’s age and evidence of shock were variables associated with the highest weight 
(Samy et al. 1994, Samy et al. 1996) and were also easily retrievable. Preoperative risk factors 
such as co-morbidities could not be reliably evaluated in the emergency room, as observed by 
Kantonen et al. (1997). The co-morbidities nevertheless had relatively less predictive weight, as 
seen in other studies as well (Samy et al. 1994, Samy et al. 1996). 
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The scoring system will hardly lead to the identification of a cut-off point beyond which the 
mortality is 100%. To the best of my knowledge, Study III is the most extensive study 
investigating the GAS after RAAA so far. If the GAS was 84 or more, 65% of patients died. If 
the GAS was >100 and age >80 years, the mortality rate was 76%. Only if the GAS was >120, 
irrespective of the patient’s age, mortality was 100%. However, there were only five patients and 
they were all over 80 years old. Tambyraja et al. (2005c) reported that in 14 patients with GAS 
>110 the operative mortality was below 50%, but they excluded the patients not selected for 
operative treatment. The subgroups of patients with advanced age and high GAS were relatively 
small for drawing definitive conclusions on how to identify patients facing immediate fatal 
outcome. 
 
Although one third of all RAAA patients aged over 80 years survived after RAAA, it was 
possible even at the oldest age quintile (80–95 years) to gain 7.9 QALYs. These results are in  
a line with other studies on over 80-year-olds: Dueck et al. (2004c) reported a 30-day operative 
mortality of 48%, Roddy et al. (2003) 41%, and Barry et al. (1998) 51%. However, these figures 
excluded elderly patients unfit for surgery, and are therefore skewed. Operative mortality rates 
for over 80-year-old patients were only slightly worse than for younger ones, which supports the 
active surgical approach. From the ethical point of view, age as such should not be used as  





Some 10% of the operative RAAA patients died intra-operatively, and a further 32% died during 
the next month, which is in accordance with previous studies (Bown et al. 2004). Postoperative 
treatment after repair of RAAA should be carried out in the intensive care unit (ICU) or high 
dependency unit. In Study IV only 2% (3/138) of the patients were not treated in the ICU, and 
they all survived as the fittest patients were transferred directly to the ward. Optimally the 
decision on whether to withdraw or continue treatment should be made only after at least 24 to 
48 hours of maximal ICU treatment. In the ICU, the cause of death was usually organ 
dysfunction (Bown et al. 2004, Meesters et al. 1994). Study IV revealed that organ dysfunction 
by day 2 SOFA score was an independent predictor for 30-day mortality. Daily measured SOFA 
scores, however, showed that the ability to distinguish between patients who die and those who 
survive was the best on day 7. Thus, day 2 seems too early for making decisions on continuing or 
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withdrawing the treatment. Despite its good predictive value, the SOFA score was unable to 
discriminate survivors from non-survivors at individual level. The SOFA score has proven its 
potential to describe organ dysfunction in critically ill patients (Vincent et al. 1998, Moreno et al. 
1999). In fact, this was the first study used SOFA to predict mortality after RAAA.  
 
The SOFA score was assigned daily, which was valuable in the standardised assessment of 
severity and duration of organ failure (Bernard 1998). The cut-off point for SOFA score is 
difficult to select, i.e. whether to simply exceed the score value or maintain it for a few days. At 
day 2 a SOFA score >11 identified 39% of non-survivors, and at day 7 63% with a high 
specificity. Junger et al. (2002) selected a cut-off point >11.5 with a sensitivity of 37%  
and a specificity of 99% in the surgical ICU with unselected patients. Cabré et al. (2005) 
demonstrated in a prospective study that 34 unselected ICU patients aged over 60 years and with 
a SOFA score above 10 for 5 days had a mortality of 100%. Recently Kaarlola et al. (2006) 
reported that all patients aged >65 years with a SOFA score greater than 15 died during their stay 
in the ICU. The patient material consisted of medical and surgical patients, 132 out of 882 were 
in the ICU for postoperative care after repair of AAA, but the share of RAAA patients was not 
available. 
 
Preoperative GAS maintained its value in predicting postoperative mortality for initial survivors 
at day 2, although the discrimination was only moderate. GAS was designed to model mortality 
of RAAA in a preoperative setting. The timing of the construction of a risk-stratification model 
dictates the potential uses of such models. The construction of such a model at the earliest time-
point in the treatment chain of a RAAA patient is unlikely to be accurate, due to the large 
number of events that the RAAA patient will have.        
 
The limitations of assessing different discrimination models need to be addressed. First, scoring 
measures such as GAS and SOFA were assigned retrospectively. As in most retrospective 
analyses, complete data were not available. In the present study, a missing variable was either 
considered normal (Glasgow Aneurysm Score II–IV) or a previous day’s value was used (SOFA 
IV). This strategy would rather underestimate than overestimate the score and its predictability. 
The decision to operate, however, was clinical, and thus the scores did not affect outcome. 
Second, as SOFA scores were not collected daily, some valuable data might be missed. In 
general, as the number of patients in the study was large, the operative rate rather high, and the 
amount of missing data small, the results seem reliable.     
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Quality of life 
 
As more than half of the hospitalised RAAA patients survived, the main question is whether 
these patients were able to live unrestricted lives postoperatively. The survivors lived at home at 
the time of the questionnaire in the present study. Dillavou et al. (2006) reported that one third of 
all RAAA patients (including non-survivors) were discharged home, and every tenth transferred 
to long-term care. Among the survivors of RAAA, QoL was nearly the same when compared to 
the norms of the age- and sex-adjusted general population; only impairment in physical 
functioning was observed (RAND-36) (I). Older patients had lower QoL in their physical 
functioning, which was also seen in the control population (Aalto et al. 1999). Co-morbidities 
also influenced adversely the functioning of the general population older than >70 years (Dunlop 
et al. 2002). When a different QoL method  (EQ-5D) was used, a lower QoL index was obtained 
than that for the age- and sex-adjusted Finnish general population, although EQ-VAS did not 
differ (II). These results with slight impairment were in line with previous studies (Magee et al. 
1992, Tambyraja et al. 2005b). Tambyraja et al. (2005b) reported functional outcome using the 
SF-36 measure. They found that role limitations due to physical and emotional problems after 
RAAA were worse than in the general population but equal with the group of elective repair of 
AAA. They also noted lower scores more often in other health domains after elective repair of 
AAA than after RAAA when compared to the general population. The good functional outcome 
after RAAA may be interpreted so that surviving from near-death has a positive effect on the 
perception of QoL. The other studies demonstrated QoL equal to that of the general population 
(Currie et al. 1992, Bohmer et al. 1999, Joseph et al. 2002, Hinterseher et al. 2004) or to the 
group of elective repair of RAAA (Hennessy et al. 1998, Tambyraja et al. 2005b).  
 
QoL is a subjective concept, based on the different perceptions of each patient’s QoL. 
Discordance between the QoL studies (I, II) could be explained by the difference in the set up of 
the health questionnaires. A wide range of scores may have reflected different outcomes after 
major surgery, and as the RAND-36 and the EQ-5D are generic measures, this may have 
influenced the sensitiveness of the measure. The RAND-36 and the EQ-5D were compared in 
critically ill patients (Kaarlola et al. 2004). The measures correlated well, but the RAND-36 
discriminated better, especially in regard to physical functioning, self-care, or low quality of life 
levels. A disease-specific measure might indicate disease severity better as observed in patients 
with peripheral arterial disease (de Vries et al. 2005). QoL measures are crude, but the present 
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data strongly contradict the belief that life after the repair of RAAA would be so poor that the 
attempt would not be worthwhile. 
    
Age or preoperative heath status based on GAS did not differ during the study years. The 
response rate was high, even though the questionnaires were filled out with the aid of a proxy in 
more than one-fourth of the cases. Bohmer et al. (1999), however, reported that the next of kin 
were prone to assess global QoL worse than the patients themselves. The importance of the 
different aspects questioned may also differ between the patient and the proxy. The study was 
retrospective, with cross-sectional QoL assessment, which may introduce bias. In this kind of 
study, it is impossible to evaluate QoL in emergency settings before the repair of RAAA. 
Patients who survived after RAAA and were able to answer the questions, represented  
a naturally selected population. Thus comparison with the appropriately adjusted general 
population as controls was fundamental. Those patients who died after hospitalisation, but before 
QoL evaluation, might have presented with lower scores due to the presence of co-morbidities. 
However, this is by far the largest study investigating QoL after repair of RAAA. 
 
The RAND-36 (based on the SF-36) was chosen because the availability of the validated Finnish 
version with age- and sex-adjusted population norms made comparison possible. The SF-36 has 
confirmed reliability, construct validity, responsiveness, and sensitivity (Black et al. 2001).         
The SF-36 is the most widely used QoL instrument in the medical literature, and it has been 
recommended in the QoL assessment of vascular diseases (Beattie et al. 1997). Results of the 
RAND-36 cannot be used as a single index for measuring QALYs and comparisons with other 
studies are difficult. Therefore we used the EQ-5D to assess the feasibility of surgery for RAAA 





RAAA patients will die without operative treatment, thus gaining 0 QALYs. Surviving patients 
gained a mean of 8.5 QALYs, but measuring QALYs only among survivors exaggerates the 
ability of the vascular service to produce QoL. Thus all RAAA patients were included, and with 
non-survivors a mean of 4.1 QALYs was obtained. Clear association was seen between QALYs 
and preoperative GAS, high GAS indicating low QALYs to be achieved. 
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Measuring QALYs is an underused approach for determining outcome after RAAA. To the best 
of my knowledge, this was the first study measuring QALYs after repair of RAAA. Life 
expectancy after the follow-up was an estimation calculated by using the age- and sex-adjusted 
life expectancy from Statistics Finland. Many studies have shown, as did Study I, that patients 
surviving more than 30 days have a life expectancy similar to that of the age- and sex-adjusted 
population (Rohrer et al. 1988, Stonebridge et al. 1993, Hinterseher et al. 2004). If the life 
expectancy had been worse among the survivors of RAAA, it would have affected the number of 
QALYs gained.  
 
The repair of RAAA was a cost-effective procedure. The cost-effectiveness ratio per survivor 
was considerably lower than the 40 000–80 000 €/QALY (50 000–100 000 USD/QALY) limit 
usually considered acceptable (Lee et al. 1996, Hamel et al. 1997, Azimi and Welch 1998, 
Finlayson and Birkmeyer 1998, Angus et al. 2003). It is comparable to the hypothetical model of 
Patel et al. (2000) (8 500 €/QALY). There were unfortunately limitations in the calculation of the 
costs, as the treatment after hospitalisation at the lower health care level was not accurately 
available. However, in their hypothetical model, Patel et al. (2000) calculated hospitalisation 
costs of 22 700 € and lifetime cost of 28 800 €. Accordingly, the cost-effectiveness ratio 
involving the lifetime costs would be 8 300 €/QALY in the present material. 
    
Cost-effectiveness was also demonstrated in patients 80 years or older. The cost-effectiveness 
ratio with a mortality rate of 76% was further lower than 40 000 €/QALY limit. The mean length 
of stay per aged survivor in the ICU was comparable with all RAAA patients, and the net costs 
were even lower. 
     
In general, the treatment of RAAA corresponds well with other surgical and medical treatments 
(Table 17) (Kuntz and Kent 1996, Patel et al. 1999, Patel et al. 2000, Schermerhorn et al. 2000, 
Eefting et al. 2003, Åhlstrom et al. 2005).  
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Table 17. Cost-effectiveness ratios for different medical procedures. 
 
Procedure Authors, year Cost-effectiveness ratio 
(€/QALY) 
CEA for symptomatic patients (ICA 
stenosis 70–99%) 
 
Kuntz et al., 1996 
 
3 300* 
Open repair of RAAA The present study 6 900 
Open repair of RAAA Patel et al., 2000 8 500* 
Open repair of AAA Schermerhorn et al., 2000 8 500* 
Coronary bypass surgery Eefting et al., 2003 11 400* 
Endovascular repair of AAA Patel et al., 1999 18 200* 
Renal replacement therapy Åhlström et al., 2005 25 500 
CEA for asymptomatic patients (ICA 
stenosis 60–99%)  
Kuntz et al., 1996 42 200* 
 
RAAA = ruptured abdominal aortic aneurysm; AAA = abdominal aortic aneurysm; CEA = carotid endarterectomy; 





Our vascular unit provides the only 24-hour, 365-day emergency vascular service in the Helsinki 
and Uusimaa district. When suspected RAAA patients’ arrive to the emergency room, bedside 
ultrasonography examination is undertaken for all RAAA patients, and computer tomography in 
selected cases. Computer tomography has been located in the emergency room since 2003. After 
the decision to operate, an RAAA patient is transferred to the operating theatre, and prepared for 
surgery before general anesthesia with a minimum of preoperative fluid resuscitation.   
 
After the organisational changes in the hospital chain were carried out, including regional 
centralisation and quality improvements, there was a decrease in the population-based mortality, 
the 90-day hospital mortality, and 30-day operative mortality. It is nevertheless not clear what 
the true causes of the improvement were. Hypotensive haemostasis, as the initial approach, has 
been advocated during the past few years. There was no preadmittance data available to clarify 
how well this treatment regimen was really used. In other series its benefit has been 
demonstrated (Roberts et al. 2006). The incidence of RAAA and demographic variables related 
to outcome did not change over the study period. The mortality rates during the years 2003–2004 
were lower than those published earlier in Finland (Kantonen et al. 1999b, Heikkinen et al. 
2002). Bown et al. (2002) reported a gradual reduction in RAAA mortality between the years 
1955–1998. However, several studies have shown no reduction in RAAA mortality over the 
years (Heller et al. 2000, Hallin et al. 2001, Visser et al. 2005). 
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Most studies reporting only operation-related mortality of RAAA surgery are skewed by the 
patient selection. 30-day mortality alone is a notoriously biased figure and apt to data 
enhancement (Campbell 1991). It is therefore mandatory to analyse the fate of all patients 
admitted alive to any given hospital, if the level of vascular or emergency services is analysed. 
Hospital mortality is a far better measure of vascular service than operative mortality. The 
inclusion of non-operated patients with known AAA, and even those diagnosed at autopsy, 
worsens the mortality rates (Callam et al. 1991). In the present study there was a small number of 
non-operated patients with diagnosed RAAA. Great variation was seen in operative activity, with 
exclusion rates ranging 7–43% (Hardman et al. 1996, Bradbury et al. 1997, Barry et al. 1998, 
Semmens et al. 1998, Adam et al. 1999, Basnyat et al. 1999, Kantonen et al. 1999b, Evans et al. 
2000, Noel et al. 2001, Heikkinen et al. 2002, Neary et al. 2003, Bown et al. 2004, Dueck et al. 
2004a, Tambyraja et al. 2005d). None of these specially included patients with undiagnosed 
RAAA. As vascular service is analysed as an entity, those patients missed by this service, 
irrespective of the reason, reflect the ability of the treatment chain to function as whole, and 
therefore even these patients need to be included.    
     
The total RAAA incidence rate of 5.4/100 000 inhabitants/year in the Helsinki and Uusimaa 
district was similar to that reported by Bengtsson et al. (1993) (5.6/100 000) and slightly lower 
than 6.1/100 000 in Finland in 1991–1994 by Kantonen et al. (1999b) or 6.3/100 000 in the 
Pirkanmaa district in 1991–1997 by Heikkinen et al. (2002). These incidences were based on all 
identified RAAA patients, also RAAA deaths outside hospital. The exact autopsy rate of the 
patients who died suddenly remains unknown during the study period. However, the autopsy rate 
in Finland was 31% of all deaths, and it was the highest in the Nordic countries (Saukko 1995). 
Registration of the cause of sudden death of elderly people (>65 years) may also be based on 
prior knowledge of a chronic/fatal disease without autopsy. Some RAAA deaths must therefore 
have escaped the data, but there was no indication that the number of missed RAAA deaths 
would have changed over the study years. 
 
Emergency surgery of AAA should be carried out by vascular specialists (Campbell and Chester 
2002). Our results of improved survival support the data of better outcomes in high-volume 
hospitals and operated by high-volume surgeons (Ouriel et al. 1990, Rutledge et al. 1996, Heller 
et al. 2000, Birkmeyer et al. 2003). The transfer times and distances from the outskirts of the 
Helsinki and Uusimaa hospital district are probably longer than before the regional 
centralisation, but this is not a time problem, as the longest distance is less than 140 km.  
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The results of prehospital care in Helsinki are good, and have been shown to be parallel in 
Europe in the chain-of-survival after cardiac arrest (Herlitz et al. 1999). Emergency medical 
service including prehospital care has improved over the years (Kuisma and Martikainen 1998) 
and may have had an impact on survival. However, most of the studies on the transfer of RAAA 
patients have shown no adverse effect of transfer time or distance on survival (Adam et al. 1999, 





The selective approach to operative treatment seems reasonable in some subgroups of RAAA 
patients, but the problem of selection still remains. Discriminator models for prognostication did 
not identify the patients with immediate fatal outcome at individual level. Prospective studies 
evaluating different preoperative scoring methods might be valuable. Measures predicting 
mortality might be used for auditing or for comparisons between hospitals.  
 
Endovascular repair of RAAA has begun to emerge as a treatment option for RAAA: 4-6% of 
RAAA patients were treated by endovascular repair in the USA in 2003 (Greco et al. 2006, 
McKinsey et al. 2006). Long-term overall mortality was lower in the endovascular group 
compared to open repair, but selection bias is obvious (Greco et al. 2006). The HUCH 
participated in a prospective multicentre study in Europe investigating endovascular repair for 
RAAA (Peppelenbosch et al. 2004, Peppelenbosch et al. 2006). The 30-day mortality was 35% 
in the endovascular group and 39% in the open repair group. It was noteworthy that a large 
number of RAAA patients was excluded from the study. However, successful endovascular 
repair needs a skilful radiology team which is available 24 hours a day. The suitability of RAAA 
for endovascular repair is also a matter of concern (Wilson et al. 2004). 
 
Cost-utility analysis, i.e. calculating QALYs and the cost-effectiveness ratio, allows future 
comparisons with other types of interventions, such as endovascular aneurysm repair. 
 
In Finland the number of people over 65 years of age will increase in the next decades by 70%. 
In the beginning of the study (1996) 14.5% of the Finnish population were over 65 years and at 
the end of the study (2004) 15.9% (Statistics Finland). In 2020 it is estimated that 23% of the 
population will be over 65 years old (Statistics Finland). If the RAAA incidence remains 
 
 73  
unchanged, the number of RAAAs will increase dramatically. Even though the repair of RAAA 
is a cost-effective procedure, it may be questioned how all RAAA patients will be treated in the 
future while the resources of the society decrease. An active treatment policy of RAAA is 








In a nationwide study population, the 30-day operative mortality was 44% for ruptured 
abdominal aortic aneurysm (RAAA) patients (III). The 30-day operative mortality and hospital 
mortality were 38% and 45%, respectively in the Helsinki University Central Hospital between 
the years 1996 to 2004 (V), whereas the population-based mortality was 69% in the Helsinki and 
Uusimaa district (V). The hospital mortality of RAAA patients over 80 years old was 66%. After 
organisational changes were undertaken, including regional centralisation, and in-hospital quality 
improvements, mortality decreased at all levels, even at the population level (V). If the level of 
vascular or emergency services is to be analysed, it is mandatory to analyse the fate of all 
patients admitted alive to hospital, not only those selected for operative treatment. 
 
Among the survivors of RAAA repair, the quality of life was nearly the same as the norms of an 
age- and sex-adjusted general population (I, II), despite impairment in physical functioning (I). 
 
RAAA patients will die without operative treatment, thus gaining 0 quality-adjusted life years 
(QALY). Successful repair of RAAA gives a mean of 4.1 (0–30.9) QALYs for all RAAA 
patients, including non-survivors (II). The repair of RAAA is a cost-effective procedure, also in 
patients aged >80 years. 
 
The preoperative Glasgow Aneurysm Score was an independent predictor of 30-day operative 
mortality at admission (III) and at 48 hours (IV) after repair of RAAA. Organ dysfunction 
measured by the Sequential Organ Failure Assessment (SOFA) score was the best predictor of 
30-day operative mortality in RAAA patients alive at 48 hours after repair of RAAA (IV).  
A high Glasgow Aneurysm Score and increased age were associated with a low number of 
QALYs after repair of RAAA (II). These results strongly support an active operation policy, as 
there is no reliable measure to predict the outcome after RAAA.   
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